AB 1386: Emergency medical care: epinephrine auto-injectors.
- Session Year: 2015-2016
- House: Assembly
- Latest Version Date: 2016-09-16
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law requires the Emergency Medical Services Authority to approve authorized training providers and the minimum standards for training and the use and administration of epinephrine auto-injectors. The existing Pharmacy Law also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime. Existing law requires school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors, as defined, to school nurses and trained personnel who have volunteered to use epinephrine auto-injectors under emergency circumstances, as specified, and authorizes school nurses and trained personnel to use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
This bill would permit an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity, as provided. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would require an authorized entity to create and maintain a specified operations plan relating to its use of epinephrine auto-injectors, and would require those entities to submit a report to the Emergency Medical Services Authority of each incident that involves the administration of an epinephrine auto-injector, not more than 30 days after each use. The bill would also require the authority to publish an annual report summarizing the reports submitted to the authority pursuant to the bills provisions. The bill would define the term epinephrine auto-injector for purposes of these provisions and other related provisions that authorize the use of epinephrine auto-injectors, as specified.
(2)Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that an authorized entity is not liable for any civil damages resulting from any act or omission connected to the administration of an epinephrine auto-injector, as specified. The bill would also exempt an authorizing physician and surgeon from certain sanctions for the issuance of an epinephrine auto-injector under those provisions, except as specified.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law requires the Emergency Medical Services Authority to approve authorized training providers and the minimum standards for training and the use and administration of epinephrine auto-injectors. The existing Pharmacy Law also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime. Existing law requires school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors, as defined, to school nurses and trained personnel who have volunteered to use epinephrine auto-injectors under emergency circumstances, as specified, and authorizes school nurses and trained personnel to use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
This bill would permit an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity, as provided. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would require an authorized entity to create and maintain a specified operations plan relating to its use of epinephrine auto-injectors, and would require those entities to submit a report to the Emergency Medical Services Authority of each incident that involves the administration of an epinephrine auto-injector, not more than 30 days after each use. The bill would also require the authority to publish an annual report summarizing the reports submitted to the authority pursuant to the bills provisions. The bill would define the term epinephrine auto-injector for purposes of these provisions and other related provisions that authorize the use of epinephrine auto-injectors, as specified.
(2)Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that an authorized entity is not liable for any civil damages resulting from any act or omission connected to the administration of an epinephrine auto-injector, as specified. The bill would also exempt an authorizing physician and surgeon from certain sanctions for the issuance of an epinephrine auto-injector under those provisions, except as specified.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law requires the Emergency Medical Services Authority to approve authorized training providers and the minimum standards for training and the use and administration of epinephrine auto-injectors. The existing Pharmacy Law also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime. Existing law requires school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors, as defined, to school nurses and trained personnel who have volunteered to use epinephrine auto-injectors under emergency circumstances, as specified, and authorizes school nurses and trained personnel to use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
This bill would permit an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity, as provided. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would require an authorized entity to create and maintain a specified operations plan relating to its use of epinephrine auto-injectors, and would require those entities to submit a report to the Emergency Medical Services Authority of each incident that involves the administration of an epinephrine auto-injector, not more than 30 days after each use. The bill would also require the authority to publish an annual report summarizing the reports submitted to the authority pursuant to the bills provisions. The bill would define the term epinephrine auto-injector for purposes of these provisions and other related provisions that authorize the use of epinephrine auto-injectors, as specified.
(2)Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that an authorized entity is not liable for any civil damages resulting from any act or omission connected to the administration of an epinephrine auto-injector, as specified. The bill would also exempt an authorizing physician and surgeon from certain sanctions for the issuance of an epinephrine auto-injector under those provisions, except as specified.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law requires the Emergency Medical Services Authority to approve authorized training providers and the minimum standards for training and the use and administration of epinephrine auto-injectors. The existing Pharmacy Law also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime. Existing law requires school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors, as defined, to school nurses and trained personnel who have volunteered to use epinephrine auto-injectors under emergency circumstances, as specified, and authorizes school nurses and trained personnel to use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
This bill would permit an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity, as provided. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would require an authorized entity to create and maintain a specified operations plan relating to its use of epinephrine auto-injectors, and would require those entities to submit a report to the Emergency Medical Services Authority of each incident that involves the administration of an epinephrine auto-injector, not more than 30 days after each use. The bill would also require the authority to publish an annual report summarizing the reports submitted to the authority pursuant to the bills provisions. The bill would define the term epinephrine auto-injector for purposes of these provisions and other related provisions that authorize the use of epinephrine auto-injectors, as specified.
(2) Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that an authorized entity is not liable for any civil damages resulting from any act or omission connected to the administration of an epinephrine auto-injector, as specified. The bill would also exempt an authorizing physician and surgeon from certain sanctions for the issuance of an epinephrine auto-injector under those provisions, except as specified.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law requires the Emergency Medical Services Authority to approve authorized training providers and the minimum standards for training and the use and administration of epinephrine auto-injectors. The existing Pharmacy Law also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime.
This bill would permit an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity, as provided. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would require an authorized entity to create and maintain a specified operations plan relating to its use of epinephrine auto-injectors, and would require those entities to submit a report to the State Department of Public Health on incidents related to Emergency Medical Services Authority of each incident that involves the administration of an epinephrine auto-injectors. auto-injector, not more than 30 days after each use. The bill would also require the department to issue authority to publish an annual report summarizing and analyzing the reports submitted to the department authority pursuant to the bills provisions.
(2) Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that an authorized entity is not liable for any civil damages resulting from any act or omission connected to the administration of an epinephrine auto-injector, as specified.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law requires the Emergency Medical Services Authority to approve authorized training providers and the minimum standards for training and the use and administration of epinephrine auto-injectors. The existing Pharmacy Law, Law also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime.
This bill would permit an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity pursuant to those provisions. entity, as provided. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would require an authorized entity to create and maintain a specified operations plan relating to its use of epinephrine auto-injectors, and would require those entities to submit a report to the State Department of Public Health on incidents related to the administration of epinephrine auto-injectors. The bill would also require the department to issue an annual report summarizing and analyzing the reports submitted to the department pursuant to the bills provisions.
(2) Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that any employee, agent, or other trained individual of an authorized entity who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards. The bill would also provide that an authorized entity is not liable for any civil damages resulting from any act or omission connected to the administration of an epinephrine auto-injector, as specified.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law requires the Emergency Medical Services Authority to approve authorized training providers and the minimum standards for training and the use and administration of epinephrine auto-injectors. The existing Pharmacy Law, also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime.
This bill would permit an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity pursuant to those provisions. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would require an authorized entity to create and maintain a specified operations plan relating to its use of epinephrine auto-injectors, and would require those entities to submit a report to the State Department of Public Health on incidents related to the administration of epinephrine auto-injectors. The bill would also require the department to issue an annual report summarizing and analyzing the reports submitted to the department pursuant to the bills provisions.
(2) Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that employees, agents, any employee, agent, or other trained individuals individual of an authorized entity who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards. The bill would also provide that an authorized entity located in this state shall not be liable, in this state, for any injuries or related damages that result from the provision or administration of an epinephrine auto-injector by its employees or agents outside of this state if the entity or its employee or agent would not have been liable for those injuries or related damages had the provision or administration occurred within this state. is not liable for any civil damages resulting from any act or omission connected to the administration of an epinephrine auto-injector, as specified.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law also requires the California Emergency Medical Services (EMS) Authority to establish or approve authorized training providers and the minimum standards for training and the use and administration of epinephrine auto-injectors, in consultation with the local emergency medical system agency, the county health department, the manufacturer, the State Department of Health Care Services, and other private organizations. The auto-injectors. The existing Pharmacy Law Law, also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime.
This bill would authorize permit an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity pursuant to those provisions. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would also require an authorized entity to create and maintain a specified operations plan relating to its use of epinephrine auto-injectors, and would require those entities to submit a report to the State Department of Public Health on incidents related to the administration of epinephrine auto-injectors, and for auto-injectors. The bill would also require the department to issue an annual report summarizing and analyzing the reports submitted to it. the department pursuant to the bills provisions.
(2) Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that employees, agents, or other trained individuals of an authorized entity who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards. The bill would also provide that an authorized entity located in this state shall not be liable, in this state, for any injuries or related damages that result from the provision or administration of an epinephrine auto-injector by its employees or agents outside of this state if the entity or its employee or agent would not have been liable for those injuries or related damages had the provision or administration occurred within this state.
The
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law authorizes a prehospital emergency medical care person, first responder, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, as specified. Existing law also requires the California Emergency Medical Services (EMS) Authority to establish or approve authorized training providers and minimum standards for training and the use and administration of epinephrine auto-injectors, in consultation with the local emergency medical system agency, the county health department, the manufacturer, the State Department of Health Care Services, and other private organizations. The Pharmacy Law also authorizes a pharmacy to dispense epinephrine auto-injectors to a prehospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with these provisions. A violation of the Pharmacy Law is a crime.
This bill would authorize an authorized entity, as defined, to use an epinephrine auto-injector to render emergency care to another person in accordance with these provisions. The bill would also authorize a pharmacy to furnish epinephrine auto-injectors to an authorized entity pursuant to those provisions. Because a violation of these provisions would be a crime, the bill would impose a state-mandated local program. The bill would also require an authorized entity to submit a report to the State Department of Public Health on incidents related to the administration of epinephrine auto-injectors, and for the department to issue an annual report summarizing and analyzing the reports submitted to it.
(2) Under existing law, everyone is generally responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. Existing law also provides that a prehospital emergency care person, first responder, or lay rescuer who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards.
This bill would provide that employees, agents, or other trained individuals of an authorized entity who administers an epinephrine auto-injector to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation, in good faith and not for compensation, is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards. The bill would also provide that an authorized entity located in this state shall not be liable, in this state, for any injuries or related damages that result from the provision or administration of an epinephrine auto-injector by its employees or agents outside of this state if the entity or its employee or agent would not have been liable for those injuries or related damages had the provision or administration occurred within this state.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Contractors State License Law, provides for the licensure and regulation of contractors by the Contractors State License Board. Existing law, based upon an investigation and probable cause, authorizes the registrar of contractors, in lieu of disciplinary proceedings, to issue a citation to a licensee, as defined, or an applicant for a license for violations of the Contractors State License Law. Existing law provides that if the licensee or applicant fails to notify the registrar that he or she intends to contest the citation within 15 working days from service of the citation, the citation is deemed a final order of the registrar and is not subject to review by any court or agency, as provided.
This bill would extend the time available for a licensee or applicant to contest that citation from 15 to 20 working days.
Existing law, the Contractors State License Law, provides for the licensure and regulation of contractors by the Contractors State License Board. Existing law, based upon an investigation and probable cause, authorizes the registrar of contractors, in lieu of disciplinary proceedings, to issue a citation to a licensee, as defined, or an applicant for a license for violations of the Contractors State License Law. Existing law provides that if the licensee or applicant fails to notify the registrar that he or she intends to contest the citation within 15 working days from service of the citation, the citation is deemed a final order of the registrar and is not subject to review by any court or agency, as provided.
This bill would extend the time available for a licensee or applicant to contest that citation from 15 to 20 working days.
Under existing law, the Department of Consumer Affairs is comprised of boards that license and regulate various professions and vocations. Existing law provides that these boards are established to ensure that private businesses and professions are regulated to protect the people of this state. Under existing law, the department is under the control of the Director of Consumer Affairs. The term director is defined for the purposes of related provisions.
This bill would make nonsubstantive changes to that definition provision.
Under existing law, the Department of Consumer Affairs is comprised of boards that license and regulate various professions and vocations. Existing law provides that these boards are established to ensure that private businesses and professions are regulated to protect the people of this state. Under existing law, the department is under the control of the Director of Consumer Affairs. The term director is defined for the purposes of related provisions.
This bill would make nonsubstantive changes to that definition provision.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, for the purpose of rendering emergency care in accordance with Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished to an authorized entity described in subdivision (a) of Section 1797.197a of the Health and Safety Code. A new prescription shall be written for any additional epinephrine auto-injectors required for use.
(b)The pharmacy shall label each epinephrine auto-injector dispensed with all of the following:
(1)The name of the person or entity to whom the prescription was issued.
(2)The designations Section 1797.197a Responder and First Aid Purposes Only.
(3)The dosage, use, and expiration date.
(c)Each dispensed prescription shall include the manufacturers product information sheet for the epinephrine auto-injector.
(d)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
(e)The epinephrine auto-injector dispensed pursuant to this section may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
(f)For purposes of this section, epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)(A)An authorized entity shall not be liable for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents who is a lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code, if the entity has complied with all applicable requirements of Section 1797.197a of the Health and Safety Code.
(B)The failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability.
(3)This subdivision does not affect any other immunity or defense that is available under law.
(c)The protection specified in paragraph (1) of subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
(e)An authorizing physician and surgeon is not subject to professional review, liable in a civil action, or subject to criminal prosecution for the issuance of a prescription or order in accordance with Section 1797.197a of the Health and Safety Code unless the physician and surgeons issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
SEC. 3.Section 49414 of the Education Code is amended to read:49414.(a)School districts, county offices of education, and charter schools shall provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered pursuant to subdivision (d), and school nurses or trained personnel may use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
(b)For purposes of this section, the following terms have the following meanings:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, an insect sting, food allergy, drug reaction, and exercise.
(2)Authorizing physician and surgeon may include, but is not limited to, a physician and surgeon employed by, or contracting with, a local educational agency, a medical director of the local health department, or a local emergency medical services director.
(3)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(4)Qualified supervisor of health may include, but is not limited to, a school nurse.
(5)Volunteer or trained personnel means an employee who has volunteered to administer epinephrine auto-injectors to a person if the person is suffering, or reasonably believed to be suffering, from anaphylaxis, has been designated by a school, and has received training pursuant to subdivision (d).
(c)Each private elementary and secondary school in the state may voluntarily determine whether or not to make emergency epinephrine auto-injectors and trained personnel available at its school. In making this determination, a school shall evaluate the emergency medical response time to the school and determine whether initiating emergency medical services is an acceptable alternative to epinephrine auto-injectors and trained personnel. A private elementary or secondary school choosing to exercise the authority provided under this subdivision shall not receive state funds specifically for purposes of this subdivision.
(d)Each public and private elementary and secondary school in the state may designate one or more volunteers to receive initial and annual refresher training, based on the standards developed pursuant to subdivision (e), regarding the storage and emergency use of an epinephrine auto-injector from the school nurse or other qualified person designated by an authorizing physician and surgeon.
(e)(1)Every five years, or sooner as deemed necessary by the Superintendent, the Superintendent shall review minimum standards of training for the administration of epinephrine auto-injectors that satisfy the requirements of paragraph (2). For purposes of this subdivision, the Superintendent shall consult with organizations and providers with expertise in administering epinephrine auto-injectors and administering medication in a school environment, including, but not limited to, the State Department of Public Health, the Emergency Medical Services Authority, the American Academy of Allergy, Asthma and Immunology, the California School Nurses Organization, the California Medical Association, the American Academy of Pediatrics, Food Allergy Research and Education, the California Society of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, the Sean N. Parker Center for Allergy Research, and others.
(2)Training established pursuant to this subdivision shall include all of the following:
(A)Techniques for recognizing symptoms of anaphylaxis.
(B)Standards and procedures for the storage, restocking, and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including calling the emergency 911 telephone number and contacting, if possible, the pupils parent and physician.
(D)Recommendations on the necessity of instruction and certification in cardiopulmonary resuscitation.
(E)Instruction on how to determine whether to use an adult epinephrine auto-injector or a junior epinephrine auto-injector, which shall include consideration of a pupils grade level or age as a guideline of equivalency for the appropriate pupil weight determination.
(F)Written materials covering the information required under this subdivision.
(3)Training established pursuant to this subdivision shall be consistent with the most recent Voluntary Guidelines for Managing Food Allergies In Schools and Early Care and Education Programs published by the federal Centers for Disease Control and Prevention and the most recent guidelines for medication administration issued by the department.
(4)A school shall retain for reference the written materials prepared under subparagraph (F) of paragraph (2).
(f)A school district, county office of education, or charter school shall distribute a notice at least once per school year to all staff that contains the following information:
(1)A description of the volunteer request stating that the request is for volunteers to be trained to administer an epinephrine auto-injector to a person if the person is suffering, or reasonably believed to be suffering, from anaphylaxis, as specified in subdivision (b).
(2)A description of the training that the volunteer will receive pursuant to subdivision (d).
(g)(1)A qualified supervisor of health at a school district, county office of education, or charter school shall obtain from an authorizing physician and surgeon a prescription for each school for epinephrine auto-injectors that, at a minimum, includes, for elementary schools, one regular epinephrine auto-injector and one junior epinephrine auto-injector, and for junior high schools, middle schools, and high schools, if there are no pupils who require a junior epinephrine auto-injector, one regular epinephrine auto-injector. A qualified supervisor of health at a school district, county office of education, or charter school shall be responsible for stocking the epinephrine auto-injector and restocking it if it is used.
(2)If a school district, county office of education, or charter school does not have a qualified supervisor of health, an administrator at the school district, county office of education, or charter school shall carry out the duties specified in paragraph (1).
(3)A prescription pursuant to this subdivision may be filled by local or mail order pharmacies or epinephrine auto-injector manufacturers.
(4)An authorizing physician and surgeon shall not be subject to professional review, be liable in a civil action, or be subject to criminal prosecution for the issuance of a prescription or order pursuant to this section, unless the physician and surgeons issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
(h)A school nurse or, if the school does not have a school nurse or the school nurse is not onsite or available, a volunteer may administer an epinephrine auto-injector to a person exhibiting potentially life-threatening symptoms of anaphylaxis at school or a school activity when a physician is not immediately available. If the epinephrine auto-injector is used it shall be restocked as soon as reasonably possible, but no later than two weeks after it is used. Epinephrine auto-injectors shall be restocked before their expiration date.
(i)A volunteer shall initiate emergency medical services or other appropriate medical followup in accordance with the training materials retained pursuant to paragraph (4) of subdivision (e).
(j)A school district, county office of education, or charter school shall ensure that each employee who volunteers under this section will be provided defense and indemnification by the school district, county office of education, or charter school for any and all civil liability, in accordance with, but not limited to, that provided in Division 3.6 (commencing with Section 810) of Title 1 of the Government Code. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteers personnel file.
(k)A state agency, the department, or a public school may accept gifts, grants, and donations from any source for the support of the public school carrying out the provisions of this section, including, but not limited to, the acceptance of epinephrine auto-injectors from a manufacturer or wholesaler.
SEC. 4.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as described in subdivision (c).
(3)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person or lay rescuer may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e).
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)(1)An authorized health care provider may issue a prescription for an epinephrine auto-injector to a prehospital emergency medical care person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is trained and qualified to administer an epinephrine auto-injector pursuant to this section or any other law.
(2)An authorized health care provider may issue a prescription for an epinephrine auto-injector to an authorized entity if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is qualified to administer an epinephrine auto-injector pursuant to this section.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall do both of the following:
(1)Create and maintain on its premises an operations plan that includes all of the following:
(A)The name and contact number for the authorized health care provider who prescribed the epinephrine auto-injector.
(B)Where and how the epinephrine auto-injector will be stored.
(C)The names of the designated employees or agents who have completed the training program required by this section and who are authorized to administer the epinephrine auto-injector.
(D)How and when the epinephrine auto-injector will be inspected for an expiration date.
(E)The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired epinephrine auto-injector or used epinephrine auto-injector in a sharps container.
(2)Submit to the authority, in a manner identified by the authority, a report of each incident that involves the use of an epinephrine auto-injector, not more than 30 days after each use. The authority shall annually publish a report that summarizes all reports submitted to it under this subdivision.
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, for the purpose of rendering emergency care in accordance with Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished to an authorized entity described in subdivision (a) of Section 1797.197a of the Health and Safety Code. A new prescription shall be written for any additional epinephrine auto-injectors required for use.
(b)The pharmacy shall label each epinephrine auto-injector dispensed with all of the following:
(1)The name of the person or entity to whom the prescription was issued.
(2)The designations Section 1797.197a Responder and First Aid Purposes Only.
(3)The dosage, use, and expiration date.
(c)Each dispensed prescription shall include the manufacturers product information sheet for the epinephrine auto-injector.
(d)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
(e)The epinephrine auto-injector dispensed pursuant to this section may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
(f)For purposes of this section, epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)(A)An authorized entity shall not be liable for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents who is a lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code, if the entity has complied with all applicable requirements of Section 1797.197a of the Health and Safety Code.
(B)The failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability.
(3)This subdivision does not affect any other immunity or defense that is available under law.
(c)The protection specified in paragraph (1) of subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
(e)An authorizing physician and surgeon is not subject to professional review, liable in a civil action, or subject to criminal prosecution for the issuance of a prescription or order in accordance with Section 1797.197a of the Health and Safety Code unless the physician and surgeons issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
SEC. 3.Section 49414 of the Education Code is amended to read:49414.(a)School districts, county offices of education, and charter schools shall provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered pursuant to subdivision (d), and school nurses or trained personnel may use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
(b)For purposes of this section, the following terms have the following meanings:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, an insect sting, food allergy, drug reaction, and exercise.
(2)Authorizing physician and surgeon may include, but is not limited to, a physician and surgeon employed by, or contracting with, a local educational agency, a medical director of the local health department, or a local emergency medical services director.
(3)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(4)Qualified supervisor of health may include, but is not limited to, a school nurse.
(5)Volunteer or trained personnel means an employee who has volunteered to administer epinephrine auto-injectors to a person if the person is suffering, or reasonably believed to be suffering, from anaphylaxis, has been designated by a school, and has received training pursuant to subdivision (d).
(c)Each private elementary and secondary school in the state may voluntarily determine whether or not to make emergency epinephrine auto-injectors and trained personnel available at its school. In making this determination, a school shall evaluate the emergency medical response time to the school and determine whether initiating emergency medical services is an acceptable alternative to epinephrine auto-injectors and trained personnel. A private elementary or secondary school choosing to exercise the authority provided under this subdivision shall not receive state funds specifically for purposes of this subdivision.
(d)Each public and private elementary and secondary school in the state may designate one or more volunteers to receive initial and annual refresher training, based on the standards developed pursuant to subdivision (e), regarding the storage and emergency use of an epinephrine auto-injector from the school nurse or other qualified person designated by an authorizing physician and surgeon.
(e)(1)Every five years, or sooner as deemed necessary by the Superintendent, the Superintendent shall review minimum standards of training for the administration of epinephrine auto-injectors that satisfy the requirements of paragraph (2). For purposes of this subdivision, the Superintendent shall consult with organizations and providers with expertise in administering epinephrine auto-injectors and administering medication in a school environment, including, but not limited to, the State Department of Public Health, the Emergency Medical Services Authority, the American Academy of Allergy, Asthma and Immunology, the California School Nurses Organization, the California Medical Association, the American Academy of Pediatrics, Food Allergy Research and Education, the California Society of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, the Sean N. Parker Center for Allergy Research, and others.
(2)Training established pursuant to this subdivision shall include all of the following:
(A)Techniques for recognizing symptoms of anaphylaxis.
(B)Standards and procedures for the storage, restocking, and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including calling the emergency 911 telephone number and contacting, if possible, the pupils parent and physician.
(D)Recommendations on the necessity of instruction and certification in cardiopulmonary resuscitation.
(E)Instruction on how to determine whether to use an adult epinephrine auto-injector or a junior epinephrine auto-injector, which shall include consideration of a pupils grade level or age as a guideline of equivalency for the appropriate pupil weight determination.
(F)Written materials covering the information required under this subdivision.
(3)Training established pursuant to this subdivision shall be consistent with the most recent Voluntary Guidelines for Managing Food Allergies In Schools and Early Care and Education Programs published by the federal Centers for Disease Control and Prevention and the most recent guidelines for medication administration issued by the department.
(4)A school shall retain for reference the written materials prepared under subparagraph (F) of paragraph (2).
(f)A school district, county office of education, or charter school shall distribute a notice at least once per school year to all staff that contains the following information:
(1)A description of the volunteer request stating that the request is for volunteers to be trained to administer an epinephrine auto-injector to a person if the person is suffering, or reasonably believed to be suffering, from anaphylaxis, as specified in subdivision (b).
(2)A description of the training that the volunteer will receive pursuant to subdivision (d).
(g)(1)A qualified supervisor of health at a school district, county office of education, or charter school shall obtain from an authorizing physician and surgeon a prescription for each school for epinephrine auto-injectors that, at a minimum, includes, for elementary schools, one regular epinephrine auto-injector and one junior epinephrine auto-injector, and for junior high schools, middle schools, and high schools, if there are no pupils who require a junior epinephrine auto-injector, one regular epinephrine auto-injector. A qualified supervisor of health at a school district, county office of education, or charter school shall be responsible for stocking the epinephrine auto-injector and restocking it if it is used.
(2)If a school district, county office of education, or charter school does not have a qualified supervisor of health, an administrator at the school district, county office of education, or charter school shall carry out the duties specified in paragraph (1).
(3)A prescription pursuant to this subdivision may be filled by local or mail order pharmacies or epinephrine auto-injector manufacturers.
(4)An authorizing physician and surgeon shall not be subject to professional review, be liable in a civil action, or be subject to criminal prosecution for the issuance of a prescription or order pursuant to this section, unless the physician and surgeons issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
(h)A school nurse or, if the school does not have a school nurse or the school nurse is not onsite or available, a volunteer may administer an epinephrine auto-injector to a person exhibiting potentially life-threatening symptoms of anaphylaxis at school or a school activity when a physician is not immediately available. If the epinephrine auto-injector is used it shall be restocked as soon as reasonably possible, but no later than two weeks after it is used. Epinephrine auto-injectors shall be restocked before their expiration date.
(i)A volunteer shall initiate emergency medical services or other appropriate medical followup in accordance with the training materials retained pursuant to paragraph (4) of subdivision (e).
(j)A school district, county office of education, or charter school shall ensure that each employee who volunteers under this section will be provided defense and indemnification by the school district, county office of education, or charter school for any and all civil liability, in accordance with, but not limited to, that provided in Division 3.6 (commencing with Section 810) of Title 1 of the Government Code. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteers personnel file.
(k)A state agency, the department, or a public school may accept gifts, grants, and donations from any source for the support of the public school carrying out the provisions of this section, including, but not limited to, the acceptance of epinephrine auto-injectors from a manufacturer or wholesaler.
SEC. 4.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as described in subdivision (c).
(3)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person or lay rescuer may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e).
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)(1)An authorized health care provider may issue a prescription for an epinephrine auto-injector to a prehospital emergency medical care person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is trained and qualified to administer an epinephrine auto-injector pursuant to this section or any other law.
(2)An authorized health care provider may issue a prescription for an epinephrine auto-injector to an authorized entity if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is qualified to administer an epinephrine auto-injector pursuant to this section.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall do both of the following:
(1)Create and maintain on its premises an operations plan that includes all of the following:
(A)The name and contact number for the authorized health care provider who prescribed the epinephrine auto-injector.
(B)Where and how the epinephrine auto-injector will be stored.
(C)The names of the designated employees or agents who have completed the training program required by this section and who are authorized to administer the epinephrine auto-injector.
(D)How and when the epinephrine auto-injector will be inspected for an expiration date.
(E)The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired epinephrine auto-injector or used epinephrine auto-injector in a sharps container.
(2)Submit to the authority, in a manner identified by the authority, a report of each incident that involves the use of an epinephrine auto-injector, not more than 30 days after each use. The authority shall annually publish a report that summarizes all reports submitted to it under this subdivision.
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, as defined by Section 1797.197a of the Health and Safety Code, for the purpose of rendering emergency care in accordance with Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished. furnished to an authorized entity described in subdivision (a) of Section 1797.197a of the Health and Safety Code. A new prescription shall be written for any additional epinephrine auto-injectors required for use.
(b)The pharmacy shall label each epinephrine auto-injector dispensed with all of the following:
(1)The name of the person or entity to whom the prescription was issued.
(2)The designations Section 1797.197a Responder and First Aid Purposes Only.
(3)The dosage, use, and expiration date.
(c)Each dispensed prescription shall include the manufacturers product information sheet for the epinephrine auto-injector.
(d)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
(e)The epinephrine auto-injector dispensed pursuant to this section may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
(f)For purposes of this section, epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)(A)An authorized entity shall not be liable for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents who is a lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code. Code, if the entity has complied with all applicable requirements of Section 1797.197a of the Health and Safety Code.
(B)The failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability.
(3)This subdivision does not affect any other immunity or defense that is available under law.
(c)The protection specified in paragraph (1) of subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
(e)An authorizing physician and surgeon is not subject to professional review, liable in a civil action, or subject to criminal prosecution for the issuance of a prescription or order pursuant to this section, in accordance with Section 1797.197a of the Health and Safety Code unless the physician and surgeons issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
SEC. 3.Section 49414 of the Education Code is amended to read:49414.(a)School districts, county offices of education, and charter schools shall provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered pursuant to subdivision (d), and school nurses or trained personnel may use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
(b)For purposes of this section, the following terms have the following meanings:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, an insect sting, food allergy, drug reaction, and exercise.
(2)Authorizing physician and surgeon may include, but is not limited to, a physician and surgeon employed by, or contracting with, a local educational agency, a medical director of the local health department, or a local emergency medical services director.
(3)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(4)Qualified supervisor of health may include, but is not limited to, a school nurse.
(5)Volunteer or trained personnel means an employee who has volunteered to administer epinephrine auto-injectors to a person if the person is suffering, or reasonably believed to be suffering, from anaphylaxis, has been designated by a school, and has received training pursuant to subdivision (d).
(c)Each private elementary and secondary school in the state may voluntarily determine whether or not to make emergency epinephrine auto-injectors and trained personnel available at its school. In making this determination, a school shall evaluate the emergency medical response time to the school and determine whether initiating emergency medical services is an acceptable alternative to epinephrine auto-injectors and trained personnel. A private elementary or secondary school choosing to exercise the authority provided under this subdivision shall not receive state funds specifically for purposes of this subdivision.
(d)Each public and private elementary and secondary school in the state may designate one or more volunteers to receive initial and annual refresher training, based on the standards developed pursuant to subdivision (e), regarding the storage and emergency use of an epinephrine auto-injector from the school nurse or other qualified person designated by an authorizing physician and surgeon.
(e)(1)Every five years, or sooner as deemed necessary by the Superintendent, the Superintendent shall review minimum standards of training for the administration of epinephrine auto-injectors that satisfy the requirements of paragraph (2). For purposes of this subdivision, the Superintendent shall consult with organizations and providers with expertise in administering epinephrine auto-injectors and administering medication in a school environment, including, but not limited to, the State Department of Public Health, the Emergency Medical Services Authority, the American Academy of Allergy, Asthma and Immunology, the California School Nurses Organization, the California Medical Association, the American Academy of Pediatrics, Food Allergy Research and Education, the California Society of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, the Sean N. Parker Center for Allergy Research, and others.
(2)Training established pursuant to this subdivision shall include all of the following:
(A)Techniques for recognizing symptoms of anaphylaxis.
(B)Standards and procedures for the storage, restocking, and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including calling the emergency 911 telephone number and contacting, if possible, the pupils parent and physician.
(D)Recommendations on the necessity of instruction and certification in cardiopulmonary resuscitation.
(E)Instruction on how to determine whether to use an adult epinephrine auto-injector or a junior epinephrine auto-injector, which shall include consideration of a pupils grade level or age as a guideline of equivalency for the appropriate pupil weight determination.
(F)Written materials covering the information required under this subdivision.
(3)Training established pursuant to this subdivision shall be consistent with the most recent Voluntary Guidelines for Managing Food Allergies In Schools and Early Care and Education Programs published by the federal Centers for Disease Control and Prevention and the most recent guidelines for medication administration issued by the department.
(4)A school shall retain for reference the written materials prepared under subparagraph (F) of paragraph (2).
(f)A school district, county office of education, or charter school shall distribute a notice at least once per school year to all staff that contains the following information:
(1)A description of the volunteer request stating that the request is for volunteers to be trained to administer an epinephrine auto-injector to a person if the person is suffering, or reasonably believed to be suffering, from anaphylaxis, as specified in subdivision (b).
(2)A description of the training that the volunteer will receive pursuant to subdivision (d).
(g)(1)A qualified supervisor of health at a school district, county office of education, or charter school shall obtain from an authorizing physician and surgeon a prescription for each school for epinephrine auto-injectors that, at a minimum, includes, for elementary schools, one regular epinephrine auto-injector and one junior epinephrine auto-injector, and for junior high schools, middle schools, and high schools, if there are no pupils who require a junior epinephrine auto-injector, one regular epinephrine auto-injector. A qualified supervisor of health at a school district, county office of education, or charter school shall be responsible for stocking the epinephrine auto-injector and restocking it if it is used.
(2)If a school district, county office of education, or charter school does not have a qualified supervisor of health, an administrator at the school district, county office of education, or charter school shall carry out the duties specified in paragraph (1).
(3)A prescription pursuant to this subdivision may be filled by local or mail order pharmacies or epinephrine auto-injector manufacturers.
(4)An authorizing physician and surgeon shall not be subject to professional review, be liable in a civil action, or be subject to criminal prosecution for the issuance of a prescription or order pursuant to this section, unless the physician and surgeons issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
(h)A school nurse or, if the school does not have a school nurse or the school nurse is not onsite or available, a volunteer may administer an epinephrine auto-injector to a person exhibiting potentially life-threatening symptoms of anaphylaxis at school or a school activity when a physician is not immediately available. If the epinephrine auto-injector is used it shall be restocked as soon as reasonably possible, but no later than two weeks after it is used. Epinephrine auto-injectors shall be restocked before their expiration date.
(i)A volunteer shall initiate emergency medical services or other appropriate medical followup in accordance with the training materials retained pursuant to paragraph (4) of subdivision (e).
(j)A school district, county office of education, or charter school shall ensure that each employee who volunteers under this section will be provided defense and indemnification by the school district, county office of education, or charter school for any and all civil liability, in accordance with, but not limited to, that provided in Division 3.6 (commencing with Section 810) of Title 1 of the Government Code. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteers personnel file.
(k)A state agency, the department, or a public school may accept gifts, grants, and donations from any source for the support of the public school carrying out the provisions of this section, including, but not limited to, the acceptance of epinephrine auto-injectors from a manufacturer or wholesaler.
SEC. 4.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as described in subdivision (c).
(3)Epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person or lay rescuer may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e).
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)(1)An authorized health care provider may issue a prescription for an epinephrine auto-injector to a prehospital emergency medical care person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is trained and qualified to administer an epinephrine auto-injector pursuant to this section or any other law.
(2)An authorized health care provider may issue a prescription for an epinephrine auto-injector to an authorized entity if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is qualified to administer an epinephrine auto-injector pursuant to this section.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall do both of the following:
(1)Create and maintain on its premises an operations plan that includes all of the following:
(A)The name and contact number for the authorized health care provider who prescribed the epinephrine auto-injector.
(B)Where and how the epinephrine auto-injector will be stored.
(C)The names of the designated employees or agents who have completed the training program required by this section and who are authorized to administer the epinephrine auto-injector.
(D)How and when the epinephrine auto-injector will be inspected for an expiration date.
(E)The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired epinephrine auto-injector or used epinephrine auto-injector in a sharps container.
(2)Submit to the authority, in a manner identified by the authority, a report of each incident that involves the use of an epinephrine auto-injector, not more than 30 days after each use. The authority shall annually publish a report that summarizes all reports submitted to it under this subdivision.
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, as defined by Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished.
(b)The pharmacy shall label each epinephrine auto-injector dispensed with all of the following:
(1)The name of the person or entity to whom the prescription was issued.
(2)The designations Section 1797.197a Responder and First Aid Purposes Only.
(3)The dosage, use, and expiration date.
(c)Each dispensed prescription shall include the manufacturers product information sheet for the epinephrine auto-injector.
(d)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
(e)The epinephrine auto-injector dispensed pursuant to this section may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
(f)For purposes of this section, epinephrine auto-injector means a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis. delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)(A)An authorized entity shall not be liable for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents who is a lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code.
(B)The failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability.
(3)This subdivision does not affect any other immunity or defense that is available under law.
(c)The protection specified in subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
(e)An authorizing physician and surgeon is not subject to professional review, liable in a civil action, or subject to criminal prosecution for the issuance of a prescription or order pursuant to this section, unless the physician and surgeons issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
SEC. 3.Section 49414 of the Education Code is amended to read:49414.(a)School districts, county offices of education, and charter schools shall provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered pursuant to subdivision (d), and school nurses or trained personnel may use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
(b)For purposes of this section, the following terms have the following meanings:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, an insect sting, food allergy, drug reaction, and exercise.
(2)Authorizing physician and surgeon may include, but is not limited to, a physician and surgeon employed by, or contracting with, a local educational agency, a medical director of the local health department, or a local emergency medical services director.
(3)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering a potentially fatal reaction to anaphylaxis. delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(4)Qualified supervisor of health may include, but is not limited to, a school nurse.
(5)Volunteer or trained personnel means an employee who has volunteered to administer epinephrine auto-injectors to a person if the person is suffering, or reasonably believed to be suffering, from anaphylaxis, has been designated by a school, and has received training pursuant to subdivision (d).
(c)Each private elementary and secondary school in the state may voluntarily determine whether or not to make emergency epinephrine auto-injectors and trained personnel available at its school. In making this determination, a school shall evaluate the emergency medical response time to the school and determine whether initiating emergency medical services is an acceptable alternative to epinephrine auto-injectors and trained personnel. A private elementary or secondary school choosing to exercise the authority provided under this subdivision shall not receive state funds specifically for purposes of this subdivision.
(d)Each public and private elementary and secondary school in the state may designate one or more volunteers to receive initial and annual refresher training, based on the standards developed pursuant to subdivision (e), regarding the storage and emergency use of an epinephrine auto-injector from the school nurse or other qualified person designated by an authorizing physician and surgeon.
(e)(1)Every five years, or sooner as deemed necessary by the Superintendent, the Superintendent shall review minimum standards of training for the administration of epinephrine auto-injectors that satisfy the requirements of paragraph (2). For purposes of this subdivision, the Superintendent shall consult with organizations and providers with expertise in administering epinephrine auto-injectors and administering medication in a school environment, including, but not limited to, the State Department of Public Health, the Emergency Medical Services Authority, the American Academy of Allergy, Asthma and Immunology, the California School Nurses Organization, the California Medical Association, the American Academy of Pediatrics, Food Allergy Research and Education, the California Society of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, the Sean N. Parker Center for Allergy Research, and others.
(2)Training established pursuant to this subdivision shall include all of the following:
(A)Techniques for recognizing symptoms of anaphylaxis.
(B)Standards and procedures for the storage, restocking, and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including calling the emergency 911 telephone number and contacting, if possible, the pupils parent and physician.
(D)Recommendations on the necessity of instruction and certification in cardiopulmonary resuscitation.
(E)Instruction on how to determine whether to use an adult epinephrine auto-injector or a junior epinephrine auto-injector, which shall include consideration of a pupils grade level or age as a guideline of equivalency for the appropriate pupil weight determination.
(F)Written materials covering the information required under this subdivision.
(3)Training established pursuant to this subdivision shall be consistent with the most recent Voluntary Guidelines for Managing Food Allergies In Schools and Early Care and Education Programs published by the federal Centers for Disease Control and Prevention and the most recent guidelines for medication administration issued by the department.
(4)A school shall retain for reference the written materials prepared under subparagraph (F) of paragraph (2).
(f)A school district, county office of education, or charter school shall distribute a notice at least once per school year to all staff that contains the following information:
(1)A description of the volunteer request stating that the request is for volunteers to be trained to administer an epinephrine auto-injector to a person if the person is suffering, or reasonably believed to be suffering, from anaphylaxis, as specified in subdivision (b).
(2)A description of the training that the volunteer will receive pursuant to subdivision (d).
(g)(1)A qualified supervisor of health at a school district, county office of education, or charter school shall obtain from an authorizing physician and surgeon a prescription for each school for epinephrine auto-injectors that, at a minimum, includes, for elementary schools, one regular epinephrine auto-injector and one junior epinephrine auto-injector, and for junior high schools, middle schools, and high schools, if there are no pupils who require a junior epinephrine auto-injector, one regular epinephrine auto-injector. A qualified supervisor of health at a school district, county office of education, or charter school shall be responsible for stocking the epinephrine auto-injector and restocking it if it is used.
(2)If a school district, county office of education, or charter school does not have a qualified supervisor of health, an administrator at the school district, county office of education, or charter school shall carry out the duties specified in paragraph (1).
(3)A prescription pursuant to this subdivision may be filled by local or mail order pharmacies or epinephrine auto-injector manufacturers.
(4)An authorizing physician and surgeon shall not be subject to professional review, be liable in a civil action, or be subject to criminal prosecution for the issuance of a prescription or order pursuant to this section, unless the physician and surgeons issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
(h)A school nurse or, if the school does not have a school nurse or the school nurse is not onsite or available, a volunteer may administer an epinephrine auto-injector to a person exhibiting potentially life-threatening symptoms of anaphylaxis at school or a school activity when a physician is not immediately available. If the epinephrine auto-injector is used it shall be restocked as soon as reasonably possible, but no later than two weeks after it is used. Epinephrine auto-injectors shall be restocked before their expiration date.
(i)A volunteer shall initiate emergency medical services or other appropriate medical followup in accordance with the training materials retained pursuant to paragraph (4) of subdivision (e).
(j)A school district, county office of education, or charter school shall ensure that each employee who volunteers under this section will be provided defense and indemnification by the school district, county office of education, or charter school for any and all civil liability, in accordance with, but not limited to, that provided in Division 3.6 (commencing with Section 810) of Title 1 of the Government Code. This information shall be reduced to writing, provided to the volunteer, and retained in the volunteers personnel file.
(k)A state agency, the department, or a public school may accept gifts, grants, and donations from any source for the support of the public school carrying out the provisions of this section, including, but not limited to, the acceptance of epinephrine auto-injectors from a manufacturer or wholesaler.
SEC. 3.SEC. 4.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as described in subdivision (c).
(3)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis. delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person or lay rescuer may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e).
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)(1)An authorized health care provider may issue a prescription for an epinephrine auto-injector to a prehospital emergency medical care person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is trained and qualified to administer an epinephrine auto-injector pursuant to this section or any other law.
(2)An authorized health care provider may issue a prescription for an epinephrine auto-injector to an authorized entity if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is qualified to administer an epinephrine auto-injector pursuant to this section.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall do both of the following:
(1)Create and maintain on its premises an operations plan that includes all of the following:
(A)The name and contact number for the authorized health care provider who prescribed the epinephrine auto-injector.
(B)Where and how the epinephrine auto-injector will be stored.
(C)The names of the designated employees or agents who have completed the training program required by this section and who are authorized to administer the epinephrine auto-injector.
(D)How and when the epinephrine auto-injector will be inspected for an expiration date.
(E)The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired epinephrine auto-injector or used epinephrine auto-injector in a sharps container.
(2)Submit to the authority, in a manner identified by the authority, a report of each incident that involves the use of an epinephrine auto-injector, not more than 30 days after each use. The authority shall annually publish a report that summarizes all reports submitted to it under this subdivision.
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 4.SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, as defined by Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished.
(b)The pharmacy shall label each epinephrine auto-injector dispensed with all of the following:
(1)The name of the person or entity to whom the prescription was issued.
(2)The designations Section 1797.197a Responder and First Aid Purposes Only.
(3)The dosage, use, and expiration date.
(c)Each dispensed prescription shall include the manufacturers product information sheet for the epinephrine auto-injector.
(d)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
(e)The epinephrine auto-injector dispensed pursuant to this section may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)(A)An authorized entity shall not be liable for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents who is a lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code.
(B)The failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability.
(3)This subdivision does not affect any other immunity or defense that is available under law.
(c)The protection specified in subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
SEC. 3.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as described in subdivision (c).
(3)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person or lay rescuer may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e).
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)(1)An authorized health care provider may issue a prescription for an epinephrine auto-injector to a prehospital emergency medical care person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is trained and qualified to administer an epinephrine auto-injector pursuant to this section or any other law.
(2)An authorized health care provider may issue a prescription for an epinephrine auto-injector to an authorized entity if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is qualified to administer an epinephrine auto-injector pursuant to this section.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall do both of the following:
(1)Create and maintain on its premises an operations plan that includes all of the following:
(A)The name and contact number for the authorized health care provider who prescribed the epinephrine auto-injector.
(B)Where and how the epinephrine auto-injector will be stored.
(C)The names of the designated employees or agents who have completed the training program required by this section and who are authorized to administer the epinephrine auto-injector.
(D)How and when the epinephrine auto-injector will be inspected for an expiration date.
(E)The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired epinephrine auto-injector or used epinephrine auto-injector in a sharps container.
(2)Submit to the State Department of Public Health, on a form developed by the State Department of Public Health, a report of each incident on the authorized entitys premises that involves the administration of an epinephrine auto-injector. The State Department of Public Health shall annually publish a report that summarizes and analyzes all reports submitted to it under this subdivision.
(2)Submit to the authority, in a manner identified by the authority, a report of each incident that involves the use of an epinephrine auto-injector, not more than 30 days after each use. The authority shall annually publish a report that summarizes all reports submitted to it under this subdivision.
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 4.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, as defined by Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for the possession of an authorized entity and for use by its employees, volunteers, and agents, first responder, or by a family member or caregiver of the person who appears to be experiencing anaphylaxis, as defined by paragraph (1) of subdivision (a) of Section 1714.23 of the Civil Code, or by the person who appears to be experiencing anaphylaxis, as defined by paragraph (1) of subdivision (a) of Section 1714.23 of the Civil Code. use by, or in connection with, an authorized entity.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished.
(b)The pharmacy shall label each epinephrine auto-injector dispensed with all of the following:
(1)The name of the person or entity to whom the prescription was issued.
(2)The designations Section 1797.197a Responder and First Aid Purposes Only.
(3)The dosage, use, and expiration date.
(c)Each dispensed prescription shall include the manufacturers product information sheet for the epinephrine auto-injector.
(d)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
(e)The epinephrine auto-injector dispensed pursuant to this section may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)An authorized health care provider that prescribes or dispenses an epinephrine auto-injector to a person described in subdivision (b) of Section 1797.197a of the Health and Safety Code or an authorized entity is not liable for any civil damages resulting from any act or omission related to the provision of an epinephrine auto-injector.
(3)A person that conducts the training described in subdivision (c) of Section 1797.197a of the Health and Safety Code is not liable for any civil damages resulting from any act or omission of the lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code, who renders emergency care by administering the epinephrine auto-injector.
(4)
(2)(A)An authorized entity shall not be liable, liable for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents who is a lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code, or who, in good faith, and not for compensation, renders emergency medical or nonmedical care at the scene of an emergency. Code.
(B)The failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability.
(5)
(3)This subdivision does not affect any other immunity or defense that is available under law, including, but not limited to, the immunity from liability for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct of a person who in good faith, and not for compensation, renders emergency medical or nonmedical care at the scene of an emergency as provided by section 1799.102 of the Health and Safety Code. law.
(c)The protection specified in subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
SEC. 3.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as described in subdivision (c).
(3)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person or lay rescuer may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e). An authorized health care provider may issue a prescription for an epinephrine auto-injector to a person described in this subdivision for the purpose of rendering emergency care to another person, upon presentation of current certification demonstrating that person is trained and qualified to administer an epinephrine auto-injector as a prehospital emergency medical care person or lay rescuer, pursuant to this section or any other statute or regulation.
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)An authorized health care provider may prescribe epinephrine auto-injectors to an authorized entity. Epinephrine auto-injectors acquired by an authorized entity shall be stored in a location readily accessible in an emergency and in accordance with the epinephrine auto-injectors instructions for use and any additional requirements that may be established by the authority.
(e)(1)An authorized health care provider may issue a prescription for an epinephrine auto-injector to a prehospital emergency medical care person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current certification demonstrating that the person is trained and qualified to administer an epinephrine auto-injector pursuant to this section or any other law.
(2)An authorized health care provider may issue a prescription for an epinephrine auto-injector to an authorized entity if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and qualified to administer an epinephrine auto-injector pursuant to this section.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall do both of the following:
(1)Create and maintain on its premises an operations plan that includes all of the following:
(A)The name and contact number for the authorized health care provider who prescribed the epinephrine auto-injector.
(B)Where and how the epinephrine auto-injector will be stored.
(C)The names of the designated employees or agents who have completed the training program required by this section and who are authorized to administer the epinephrine auto-injector.
(D)How and when the epinephrine auto-injector will be inspected for an expiration date.
(E)The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired epinephrine auto-injector. auto-injector or used epinephrine auto-injector in a sharps container.
(2)Submit to the State Department of Public Health, on a form developed by the State Department of Public Health, a report of each incident on the authorized entitys premises that involves the administration of an epinephrine auto-injector. The State Department of Public Health shall annually publish a report that summarizes and analyzes all reports submitted to it under this subdivision.
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 4.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, as defined by Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for use at or in connection with an authorized entity. the possession of an authorized entity and for use by its employees, volunteers, and agents, first responder, or by a family member or caregiver of the person who appears to be experiencing anaphylaxis, as defined by paragraph (1) of subdivision (a) of Section 1714.23 of the Civil Code, or by the person who appears to be experiencing anaphylaxis, as defined by paragraph (1) of subdivision (a) of Section 1714.23 of the Civil Code.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished.
(b)The pharmacy shall label each epinephrine auto-injector dispensed with all of the following:
(1)The name of the person or entity to whom the prescription was issued.
(2)The designations Section 1797.197a Responder and First Aid Purposes Only.
(3)The dosage, use, and expiration date.
(c)Each dispensed prescription shall include the manufacturers product information sheet for the epinephrine auto-injector.
(d)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
(e)The epinephrine auto-injector dispensed pursuant to this section may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code or employees, agents, or other trained individuals of an authorized entity, as defined by paragraph (2) of subdivision (a) of Section 1797.197a of the Health and Safety Code, who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)An authorized health care provider that prescribes or dispenses an epinephrine auto-injector or a pharmacist that dispenses an epinephrine auto-injector to a person described in subdivision (b) of Section 1797.197a of the Health and Safety Code or an authorized entity is not liable for any civil damages resulting from any act or omission related to the provision of an epinephrine auto-injector.
(3)A person that conducts the training described in subdivision (c) of Section 1797.197a of the Health and Safety Code is not liable for any civil damages resulting from any act or omission related to the acquisition, possession, administration, or provision of an of the lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code, who renders emergency care by administering the epinephrine auto-injector.
(4)(A)An authorized entity located in this state shall not be liable, in this state, for any injuries or related damages that result from the provision or for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by its employees or agents outside of this state if the entity or its employee or agent would not have been liable for those injuries or related damages had the provision or administration occurred within this state. any one of its employees, volunteers, or agents who is a lay rescuer, as defined by paragraph (4) of subdivision (a) of Section 1797.197a of the Health and Safety Code, or who, in good faith, and not for compensation, renders emergency medical or nonmedical care at the scene of an emergency.
(5)An authorized entity that possesses and makes available epinephrine auto-injectors, including third parties that facilitate the availability of epinephrine auto-injectors to an authorized entity, is not liable for any injuries or related damages that result from any act or omission taken pursuant to this section.
(B)The failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability.
(6)
(5)This subdivision does not eliminate, limit, or reduce affect any other immunity or defense that may otherwise be is available under state law. law, including, but not limited to, the immunity from liability for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct of a person who in good faith, and not for compensation, renders emergency medical or nonmedical care at the scene of an emergency as provided by section 1799.102 of the Health and Safety Code.
(c)The protection specified in subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
SEC. 3.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any for-profit, nonprofit, or government entity or organization in connection with, or at which, allergens capable of causing anaphylaxis may be present, including, but not limited to, recreation camps, colleges and universities, day care facilities, youth sports leagues, amusement parks, restaurants, places of employment, and sports arenas. that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as described in subdivision (c).
(3)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person, lay rescuer, or employees, agents, or other trained individuals of an authorized entity person or lay rescuer may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e). An authorized health care provider may issue a prescription for an epinephrine auto-injector to a person described in this subdivision for the purpose of rendering emergency care to another person, upon presentation of current certification demonstrating that person is trained and qualified to administer an epinephrine auto-injector as a prehospital emergency medical care person or lay rescuer, pursuant to this section or any other statute or regulation.
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)An authorized health care provider may prescribe epinephrine auto-injectors to an authorized entity or to an employee or agent of an authorized entity who holds a valid certification demonstrating that the person is trained and qualified to administer an epinephrine auto-injector as a lay rescuer. entity. Epinephrine auto-injectors acquired by an authorized entity shall be stored in a location readily accessible in an emergency and in accordance with the epinephrine auto-injectors instructions for use and any additional requirements that may be established by the authority.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall do both of the following:
(1)Create and maintain on its premises an operations plan that includes all of the following:
(A)The name and contact number for the authorized health care provider who prescribed the epinephrine auto-injector.
(B)Where and how the epinephrine auto-injector will be stored.
(C)The names of the designated employees or agents who have completed the training program required by this section and who are authorized to administer the epinephrine auto-injector.
(D)How and when the epinephrine auto-injector will be inspected for an expiration date.
(E)The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired epinephrine auto-injector.
(2)Submit to the State Department of Public Health, on a form developed by the State Department of Public Health, a report of each incident on the authorized entitys premises that involves the administration of an epinephrine auto-injector. The State Department of Public Health shall annually publish a report that summarizes and analyzes all reports submitted to it under this subdivision.
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 4.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, as defined by Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for use at or in connection with an authorized entity.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished.
(b)The pharmacy shall label each epinephrine auto-injector dispensed with all of the following:
(1)The name of the person or entity to whom the prescription was issued.
(2)The designations Section 1797.197a Responder and First Aid Purposes Only.
(3)The dosage, use, and expiration date.
(c)Each dispensed prescription shall include the manufacturers product information sheet for the epinephrine auto-injector.
(b)
(d)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
(e)The epinephrine auto-injector dispensed pursuant to this section may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code or employees, agents, or other trained individuals of an authorized entity, as defined by paragraph (2) of subdivision (a) of Section 1797.197a of the Health and Safety Code, who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)An authorized health care provider that prescribes or dispenses an epinephrine auto-injector or a pharmacist that dispenses an epinephrine auto-injector to a person described in subdivision (b) of Section 1797.197a of the Health and Safety Code or an authorized entity is not liable for any civil damages resulting from any act or omission related to the provision of an epinephrine auto-injector.
(3)A person that conducts the training described in subdivision (c) of Section 1797.197a of the Health and Safety Code is not liable for any civil damages resulting from any act or omission related to the acquisition, possession, administration, or provision of an epinephrine auto-injector.
(4)An authorized entity located in this state shall not be liable, in this state, for any injuries or related damages that result from the provision or administration of an epinephrine auto-injector by its employees or agents outside of this state if the entity or its employee or agent would not have been liable for those injuries or related damages had the provision or administration occurred within this state.
(5)An authorized entity that possesses and makes available epinephrine auto-injectors, including third parties that facilitate the availability of epinephrine auto-injectors to an authorized entity, is not liable for any injuries or related damages that result from any act or omission taken pursuant to this section.
(5)
(6)This subdivision does not eliminate, limit, or reduce any other immunity or defense that may otherwise be available under state law.
(c)The protection specified in subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
SEC. 3.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any entity or organization in connection with, or at which, allergens capable of causing anaphylaxis may be present, including, but not limited to, recreation camps, colleges and universities, day care facilities, youth sport sports leagues, amusement parks, restaurants, places of employment, and sports arenas.
(3)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person, lay rescuer, or employees, agents, or other trained individuals of an authorized entity may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e). An authorized health care provider may issue a prescription for an epinephrine auto-injector to a person described in this subdivision for the purpose of rendering emergency care to another person, upon presentation of current certification demonstrating that person is trained and qualified to administer an epinephrine auto-injector as a prehospital emergency medical care person or lay rescuer, pursuant to this section or any other statute or regulation.
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the California Emergency Medical Services (EMS) Authority. authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the EMS Authority authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director of the authority may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)An authorized health care provider may prescribe epinephrine auto-injectors to an authorized entity or to an employee or agent of which that an authorized entity who holds a current valid certification demonstrating that the person is trained and qualified to administer an epinephrine auto-injector as a lay rescuer. Epinephrine auto-injectors acquired by an authorized entity shall be stored in a location readily accessible in an emergency and in accordance with the epinephrine auto-injectors instructions for use and any additional requirements that may be established by the EMS Authority. authority.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall submit do both of the following:
(1)Create and maintain on its premises an operations plan that includes all of the following:
(A)The name and contact number for the authorized health care provider who prescribed the epinephrine auto-injector.
(B)Where and how the epinephrine auto-injector will be stored.
(C)The names of the designated employees or agents who have completed the training program required by this section and who are authorized to administer the epinephrine auto-injector.
(D)How and when the epinephrine auto-injector will be inspected for an expiration date.
(E)The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired epinephrine auto-injector.
(2)Submit to the State Department of Public Health, on a form developed by the State Department of Public Health, a report of each incident on the authorized entitys premises that involves the administration of an epinephrine auto-injector. The State Department of Public Health shall annually publish a report that summarizes and analyzes all reports submitted to it under this subdivision.
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 4.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, as defined by Section 1797.197a of the Health and Safety Code, if both of the following requirements are met:
(1)The epinephrine auto-injectors are furnished exclusively for use at or in connection with an authorized entity.
(2)An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished.
(b)Records regarding the acquisition and disposition of epinephrine auto-injectors furnished pursuant to subdivision (a) shall be maintained by the authorized entity for a period of three years from the date the records were created. The authorized entity shall be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
SEC. 2.Section 1714.23 of the Civil Code is amended to read:1714.23.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(b)(1)Any person described in subdivision (b) of Section 1797.197a of the Health and Safety Code or employees, agents, or other trained individuals of an authorized entity, as defined by paragraph (2) of subdivision (a) of Section 1797.197a of the Health and Safety Code, who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of the Health and Safety Code.
(2)An authorized health care provider that prescribes an epinephrine auto-injector to a person described in subdivision (b) of Section 1797.197a of the Health and Safety Code or an authorized entity is not liable for any civil damages resulting from any act or omission related to the provision of an epinephrine auto-injector.
(3)A person that conducts the training described in subdivision (c) of Section 1797.197a of the Health and Safety Code is not liable for any civil damages resulting from any act or omission related to the acquisition, possession, administration, or provision of an epinephrine auto-injector.
(4)An authorized entity located in this state shall not be liable, in this state, for any injuries or related damages that result from the provision or administration of an epinephrine auto-injector by its employees or agents outside of this state if the entity or its employee or agent would not have been liable for those injuries or related damages had the provision or administration occurred within this state.
(5)This subdivision does not eliminate, limit, or reduce any other immunity or defense that may otherwise be available under state law.
(c)The protection specified in subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.
(d)Nothing in this section relieves a manufacturer, designer, developer, distributor, or supplier of an epinephrine auto-injector of liability under any other applicable law.
SEC. 3.Section 1797.197a of the Health and Safety Code is amended to read:1797.197a.(a)For purposes of this section, the following definitions shall apply:
(1)Anaphylaxis means a potentially life-threatening hypersensitivity or allergic reaction to a substance.
(A)Symptoms of anaphylaxis may include shortness of breath, wheezing, difficulty breathing, difficulty talking or swallowing, hives, itching, swelling, shock, or asthma.
(B)Causes of anaphylaxis may include, but are not limited to, insect stings or bites, foods, drugs, and other allergens, as well as idiopathic or exercise-induced anaphylaxis.
(2)Authorized entity means any entity or organization in connection with, or at which, allergens capable of causing anaphylaxis may be present, including, but not limited to, recreation camps, colleges and universities, day care facilities, youth sport leagues, amusement parks, restaurants, places of employment, and sports arenas.
(2)
(3)Epinephrine auto-injector means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
(3)
(4)Lay rescuer means any person who has met the training standards and other requirements of this section but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
(4)
(5)Prehospital emergency medical care person has the same meaning as defined in paragraph (2) of subdivision (a) of Section 1797.189.
(b)A prehospital emergency medical care person or person, lay rescuer rescuer, or employees, agents, or other trained individuals of an authorized entity may use an epinephrine auto-injector to render emergency care to another person if all of the following requirements are met:
(1)The epinephrine auto-injector is legally obtained by prescription from an authorized health care provider. provider or from an authorized entity that acquired the epinephrine auto-injector pursuant to subdivision (e). An authorized health care provider may issue a prescription for an epinephrine auto-injector to a person described in this subdivision for the purpose of rendering emergency care to another person, upon presentation of current certification demonstrating that person is trained and qualified to administer an epinephrine auto-injector as a prehospital emergency medical care person or lay rescuer, pursuant to this section or any other statute or regulation.
(2)The epinephrine auto-injector is used on another, with the expressed or implied consent of that person, to treat anaphylaxis.
(3)The epinephrine auto-injector is stored and maintained as directed by the manufacturers instructions for that product.
(4)The person using the epinephrine auto-injector has successfully completed a course of training with an authorized training provider, as described in subdivision (c), and has current certification of training issued by the provider.
(5)The epinephrine auto-injectors obtained by prehospital emergency medical care personnel pursuant to Section 4119.3 of the Business and Professions Code shall be used only when functioning outside the course of the persons occupational duties, or as a volunteer, pursuant to this section.
(6)The Emergency Medical Services System is activated as soon as practicable when an epinephrine auto-injector is used.
(c)(1)The authorized training providers shall be approved, and the minimum standards for training and the use and administration of epinephrine auto-injectors pursuant to this section shall be established and approved, by the California Emergency Medical Services (EMS) Authority. The authority may designate existing training standards for the use and administration of epinephrine auto-injectors by prehospital emergency medical care personnel to satisfy the requirements of this section.
(2)The minimum training and requirements shall include all of the following components:
(A)Techniques for recognizing circumstances, signs, and symptoms of anaphylaxis.
(B)Standards and procedures for proper storage and emergency use of epinephrine auto-injectors.
(C)Emergency followup procedures, including activation of the Emergency Medical Services System, by calling the emergency 9-1-1 telephone number or otherwise alerting and summoning more advanced medical personnel and services.
(D)Compliance with all regulations governing the training, indications, use, and precautions concerning epinephrine auto-injectors.
(E)Written material covering the information required under this provision, including the manufacturer product information sheets on commonly available models of epinephrine auto-injectors.
(F)Completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator (AED) for infants, children, and adults that complies with regulations adopted by the EMS Authority and the standards of the American Heart Association or the American Red Cross, and a current certification for that training.
(3)Training certification shall be valid for no more than two years, after which recertification with an authorized training provider is required.
(4)The director of the authority may, in accordance with regulations adopted by the authority, deny, suspend, or revoke any approval issued under this subdivision or may place any approved training provider on probation upon a finding by the director of an imminent threat to public health and safety, as evidenced by any of the following:
(A)Fraud.
(B)Incompetence.
(C)The commission of any fraudulent, dishonest, or corrupt act that is substantially related to the qualifications, functions, or duties of training program directors or instructors.
(D)Conviction of any crime that is substantially related to the qualifications, functions, or duties of training program directors or instructors. The record of conviction or a certified copy of the record shall be conclusive evidence of the conviction.
(E)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of, or conspiring to violate, any provision of this section or the regulations promulgated by the authority pertaining to the review and approval of training programs in anaphylaxis and the use and administration of epinephrine auto-injectors, as described in this subdivision.
(d)(1)The authority shall assess a fee pursuant to regulation sufficient to cover the reasonable costs incurred by the authority for the ongoing review and approval of training and certification under subdivision (c).
(2)The fees shall be deposited in the Specialized First Aid Training Program Approval Fund, which is hereby created in the State Treasury. All moneys deposited in the fund shall be made available, upon appropriation, to the authority for purposes described in paragraph (1).
(3)The authority may transfer unused portions of the Specialized First Aid Training Program Approval Fund to the Surplus Money Investment Fund. Funds transferred to the Surplus Money Investment Fund shall be placed in a separate trust account, and shall be available for transfer to the Specialized First Aid Training Program Approval Fund, together with the interest earned, when requested by the authority.
(4)The authority shall maintain a reserve balance in the Specialized First Aid Training Program Approval Fund of 5 percent of annual revenues. Any increase in the fees deposited in the Specialized First Aid Training Program Approval Fund shall be effective upon determination by the authority that additional moneys are required to fund expenditures pursuant to subdivision (c).
(e)An authorized health care provider may prescribe epinephrine auto-injectors to an authorized entity or to an employee or agent of which that holds a current certification demonstrating that the person is trained and qualified to administer an epinephrine auto-injector as a lay rescuer. Epinephrine auto-injectors acquired by an authorized entity shall be stored in a location readily accessible in an emergency and in accordance with the epinephrine auto-injectors instructions for use and any additional requirements that may be established by the EMS Authority.
(f)An authorized entity that possesses and makes available epinephrine auto-injectors shall submit to the State Department of Public Health, on a form developed by the State Department of Public Health, a report of each incident on the authorized entitys premises that involves the administration of an epinephrine auto-injector. The State Department of Public Health shall annually publish a report that summarizes and analyzes all reports submitted to it under this subdivision.
(e)
(g)This section shall not apply to a school district or county office of education, or its personnel, that provides and utilizes epinephrine auto-injectors to provide emergency medical aid pursuant to Section 49414 of the Education Code.
(f)
(h)This section shall not be construed to limit or restrict the ability of prehospital emergency medical care personnel, under any other statute or regulation, to administer epinephrine, including the use of epinephrine auto-injectors, or to require additional training or certification beyond what is already required under the other statute or regulation.
SEC. 4.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SECTION 1.Section 7099.4 of the Business and Professions Code is amended to read:7099.4.If within 20 working days from service of the citation issued by the registrar, the licensee or applicant for licensure fails to notify the registrar that he or she intends to contest the citation, the citation shall be deemed a final order of the registrar and not be subject to review by any court or agency. The 20-day period may be extended by the registrar for cause.
If within 15 20 working days from service of the citation issued by the registrar, the licensee or applicant for licensure fails to notify the registrar that he or she intends to contest the citation, the citation shall be deemed a final order of the registrar and not be subject to review by any court or agency. The 15-day 20-day period may be extended by the registrar for cause.
SECTION 1.Section 302 of the Business and Professions Code is amended to read:302.As used in this chapter, the following terms shall have the following meanings:
(a)Department means the Department of Consumer Affairs.
(b)Director means the Director of Consumer Affairs.
(c)Consumer means any individual who seeks or acquires, by purchase or lease, any goods, services, money, or credit for personal, family, or household purposes.
(d)Person means an individual, partnership, corporation, limited liability company, association, or other group, however organized.
(e)Individual does not include a partnership, corporation, association, or other group, however organized.
(f)Division means the Division of Consumer Services.
(g)Interests of consumers is limited to the cost, quality, purity, safety, durability, performance, effectiveness, dependability, availability, and adequacy of choice of goods and services offered or furnished to consumers and the adequacy and accuracy of information relating to consumer goods, services, money, or credit (including labeling, packaging, and advertising of contents, qualities, and terms of sales).
As used in this chapter, the following terms shall have the following meanings:
(a)Department means the Department of Consumer Affairs.
(b)Director means the Director of the Department of Consumer Affairs.
(c)Consumer means any individual who seeks or acquires, by purchase or lease, any goods, services, money, or credit for personal, family, or household purposes.
(d)Person means an individual, partnership, corporation, limited liability company, association, or other group, however organized.
(e)Individual does not include a partnership, corporation, association, or other group, however organized.
(f)Division means the Division of Consumer Services.
(g)Interests of consumers is limited to the cost, quality, purity, safety, durability, performance, effectiveness, dependability, availability, and adequacy of choice of goods and services offered or furnished to consumers and the adequacy and accuracy of information relating to consumer goods, services, money, or credit (including labeling, packaging, and advertising of contents, qualities, and terms of sales).
|
Date
|
Status
|
|---|---|
| Sep 16, 2016 | Chaptered by Secretary of State - Chapter 374, Statutes of 2016. |
| Sep 16, 2016 | Approved by the Governor. |
| Aug 26, 2016 | Enrolled and presented to the Governor at 4:30 p.m. |
| Aug 22, 2016 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0. Page 6052.). |
| Aug 22, 2016 | Senate amendments concurred in. To Engrossing and Enrolling. |
| Aug 16, 2016 | Read third time. Passed. Ordered to the Assembly. (Ayes 38. Noes 0. Page 5023.). |
| Aug 16, 2016 | Read third time. Passed. Ordered to the Assembly. (Ayes 38. Noes 0.). |
| Aug 16, 2016 | In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 18 pursuant to Assembly Rule 77. |
| Aug 16, 2016 | Read third time. Passed. Ordered to the Assembly. |
| Aug 15, 2016 | Read second time. Ordered to third reading. |
| Aug 11, 2016 | From committee: Do pass. (Ayes 7. Noes 0.) (August 11). |
| Aug 1, 2016 | In committee: Referred to APPR. suspense file. |
| Jun 28, 2016 | Read second time and amended. Re-referred to Com. on APPR. |
| Jun 27, 2016 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 7. Noes 0.) (June 21). |
| Jun 13, 2016 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on JUD. |
| Jun 8, 2016 | From committee: Do pass and re-refer to Com. on JUD. (Ayes 7. Noes 0.) (June 8). Re-referred to Com. on JUD. |
| May 31, 2016 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. |
| Feb 4, 2016 | Referred to Coms. on HEALTH and JUD. |
| Jan 27, 2016 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Jan 27, 2016 | Read third time. Passed. Ordered to the Senate. (Ayes 78. Noes 0. Page 3510.) |
| Jan 21, 2016 | Read second time. Ordered to Consent Calendar. |
| Jan 21, 2016 | From committee: Do pass. To Consent Calendar. (Ayes 17. Noes 0.) (January 21). |
| Jan 15, 2016 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (January 15). Re-referred to Com. on APPR. |
| Jan 14, 2016 | Re-referred to Com. on JUD. |
| Jan 13, 2016 | Read second time and amended. |
| Jan 12, 2016 | From committee: Amend, and do pass as amended and re-refer to Com. on JUD. (Ayes 14. Noes 0.) (January 12). |
| Jan 7, 2016 | (pending re-refer to Com. on JUD.) |
| Jan 7, 2016 | Assembly Rule 56 suspended. (Page 3367.) |
| Jan 6, 2016 | Re-referred to Com. on B. & P. |
| Jan 5, 2016 | From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended. |
| Jan 4, 2016 | Re-referred to Com. on B. & P. |
| Jan 4, 2016 | From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended. |
| Apr 28, 2015 | In committee: Hearing postponed by committee. |
| Apr 23, 2015 | From committee: Be re-referred to Coms. on B. & P. and JUD. (Ayes 10. Noes 0.) (April 23). Re-referred to Com. on B. & P. |
| Apr 20, 2015 | Re-referred to Com. on RLS. pursuant to Assembly Rule 96. |
| Apr 20, 2015 | Re-referred to Com. on B. & P. |
| Apr 16, 2015 | From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended. |
| Apr 6, 2015 | Re-referred to Com. on B. & P. |
| Mar 26, 2015 | From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended. |
| Mar 26, 2015 | Referred to Com. on B. & P. |
| Mar 2, 2015 | Read first time. |
| Mar 1, 2015 | From printer. May be heard in committee March 31. |
| Feb 27, 2015 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 22, 2016 | AB 1386 LOW Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Aug 16, 2016 | Assembly 3rd Reading AB1386 Low By Huff | Senate Floor |
Passed |
|
| Aug 11, 2016 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| Aug 1, 2016 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Jun 21, 2016 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | Senate Standing Committee on Judiciary |
Passed |
|
| Jun 8, 2016 | Do pass, but first be re-referred to the Committee on [Judiciary] | Senate Standing Committee on Health |
Passed |
|
| Jan 27, 2016 | AB 1386 LOW Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Jan 21, 2016 | Do pass. To Consent Calendar. | Assembly Standing Committee on Appropriations |
Passed |
|
| Jan 15, 2016 | Do pass and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Judiciary |
Passed |
|
| Jan 12, 2016 | Do pass as amended and be re-referred to the Committee on [Judiciary] | Assembly Standing Committee on Business and Professions |
Passed |
|
| Apr 23, 2015 | Be re-referred to the Committee on [Business and Professions] | Assembly Standing Committee on Rules |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 1386
Author:(Low)
As Amended Ver:June 28, 2016
Majority vote
ASSEMBLY: | 78-0 | (January 27, 2016) | SENATE: | 38-0 | (August 16, 2016) |
Original Committee Reference: B. & P.
SUMMARY: Permits a pharmacy to furnish epinephrine auto-injectors (EAIs) to an authorized entity, as specified, if the EAIs are furnished exclusively for use at or in connection with an authorized entity, as specified; an authorized health care provider provides a prescription; and, the records are maintained by the authorized entity for three years. Requires the authorized entity to create and maintain an operations plan related to its use of EAIs; makes other technical and clarifying amendments; and, contains specified immunity provisions. Specifically, this bill:
- Permits a pharmacy to furnish EAIs to an authorized entity for the purpose of rendering emergency care, as specified, if both the following conditions are met:
- The EAIs are furnished exclusively for use by or in connection with an authorized entity; and,
- An authorized health care provider provides a prescription that specifies the quantity of EAIs to be furnished to an authorized entity, as specified, and a new prescription is written for any additional EAIs required for use.
- Requires a pharmacy to label each EAI dispensed with all of the following information:
- The name of the person or entity to whom the prescription was issued;
- The designations "Section 1797.197a Responder" and "First Aid Purposes Only"; and,
- The dosage, use, and expiration date.
- Requires each dispensed prescription to include the manufacturer's product information sheet for the EAI.
- States that an EAI dispensed, as specified, may be used only for the purpose and under the circumstances described in the Health and Safety Code (HSC) Section 1797.197a.
- Defines an "EAI" to mean a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to treat a life-threating allergic reaction.
- Replaces previous definitions of an EAI with 5) above.
- Requires records regarding the acquisition and disposition of EAIs to be maintained by the authorized entity for a period of three years from the date the records were created and requires the authorized entity to be responsible for monitoring the supply of EAIs and ensuring the destruction of expired EAIs.
- Relieves any authorized entity from liability for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an EAI by any one of its employees, volunteers, or agents who is a lay rescuer, as specified, if the entity has complied with all applicable requirements of the HSC Section 1797.197a.
- States that the failure of an authorized entity to possess or administer an EAI cannot result in civil liability.
- Specifies that above the provisions does not affect any other immunity or defense that is available under law.
- Specifies that an authorizing physician and surgeon is not subject to professional review, liable in a civil action, or subject to criminal prosecution for the issuance of a prescription or order in accordance with HSC Section 1797.197a unless the prescription or order constitutes gross negligence or willful or malicious conduct.
- Defines an "authorized entity" as any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as specified.
- Permits an authorized health care provider to issue a prescription for an EAI to a prehospital emergency medical care person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current EAI certification card demonstrating that the person is trained and qualified to administer an EAI, as specified.
- Permits an authorized health care provider to issue a prescription for an EAI to an authorized entity if the authorized entity submits evidence it employs at least one person, or utilized at least one volunteer or agent, who is trained and has a current EAI certification card demonstrating that the person is qualified to administer an EAI, as specified.
- Requires an authorized entity that possesses and makes available EAIs to do both of the following:
- Create and maintain on its premises an operation plan that includes all of the following:
- The name and contact number for the authorized health care provider who prescribed the EAI;
- Where and how the EAI will be stored;
- The names of the of the designated employees or agents who have completed the training program as required and who are authorized to administer the EAI;
- How and when the EAI will be inspected for an expiration date; and,
- The process to replace the expired EAI, including the proper disposal of an expired EAI.
- Submit to the authority a report of each incident that involves the use of an EAI not more than 30 days after each use, and requires the authority to annually publish a report that summarizes and analyzes all reports submitted to it.
- Create and maintain on its premises an operation plan that includes all of the following:
- Makes other technical and clarifying amendments.
- Provides that no reimbursement is required by this bill pursuant to California Constitution Article XIII B Section 6 because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction.
The Senate amendments revise and replace the definition of an EAI; specify that an authorizing physician and surgeon is not subject to professional review, be liable in a civil action or subject to criminal prosecution for the issuance of a prescription of an EAI, unless the issuance constitutes gross negligence or willful or malicious conduct; revise the requirements for an authorized health care provider to issue a prescription; and make other technical and clarifying changes.
FISCAL EFFECT: According to the Senate Appropriations Committee, this bill will result in:
- One-time costs of $50,000 for the development of information technology systems to track information relating to the issuance of certificates and collection of data on usage of epinephrine auto-injectors under the bill by the Emergency Medical Services Authority (General Fund).
- One-time costs of $130,000 over two years for the adoption of regulations by the Emergency Medical Services Authority (General Fund).
- Ongoing costs of $90,000 per year to review training programs, issue certificates to participating individuals, and report data on the program by the Emergency Medical Services Authority (General Fund).
COMMENTS:
Purpose. This bill is sponsored by Mylan. According to the author, "Food allergies, which can sometimes lead to a life-threatening allergic reaction or anaphylaxis, are a large and growing public health problem. Today, an estimated one out of 13 children and [one] out of 20 adults in the United States (U.S.) has a food allergy, a considerably higher number than estimated only a few [years] ago. [Additionally] children and adults are allergic to insect stings and other factors that can result in anaphylaxis. Unfortunately, over the past several years, there have been several high profile anaphylaxis-related tragedies around the country in schools and outside of schools. Deaths in Illinois in 2011, Georgia and Virginia in 2012, California, Texas and New York (in 2013) resulted in significant attention to the issue and much discussion on how to best address it…
This issue is serious and 47 states, including California, now have laws to allow or mandate schools to stock [EAIs]. At least 54,000 schools across the U.S. are stocking [EAIs]. But schools are not the only place where children can come into contact with allergens capable of causing anaphylaxis. Greater access is needed to allow businesses, organization[s] and other entities to stock [EAIs] and allow for trained employees, agents and others to use those [EAIs] in an emergency.
This legislation would expand access and allow day care [facilities], colleges and universities, summer and day camps, restaurants, sports arenas, sports leagues, scout troops, before and after school programs, recreational parks and other places where children and adults could come into contact with potentially life-threatening allergens to stock [EAIs] and be better prepared in the event of an emergency. It would not require any entity to stock [EAIs], but would simply allow it."
Background. An EAI is used for the emergency treatment of severe allergic reactions (including anaphylaxis) to insect bites or stings, medicines, foods, or other substances. It is also used to treat anaphylaxis caused by unknown substances or triggered by exercise. To help increase access to EAIs in the event of an anaphylactic emergency, this bill will allow a pharmacy to furnish EAIs to authorized entities such as recreation camps, colleges and universities, day care facilities, youth sports leagues and other businesses to be used by trained persons in the event of a potential anaphylactic emergency. In order for the entity to acquire the EAIs, they would need to obtain a prescription from an authorized health care provider who would be responsible for determining the appropriate number of EAIs to be dispensed. The representative of the authorized entity would need to meet the appropriate training requirements as approved by the Emergency Medical Services Authority (EMS).
The author notes, that while existing law allows individuals who have been trained in recognition of symptoms of allergic reactions and anaphylaxis to administer EAIs to others in an emergency situation, and provides liability protection for these individuals, current law does not allow a business, group, or other entity that the individual is employed by or associated with to obtain a prescription for an EAI or to have liability protection if the EAI is used on the entity's premises.
This bill would allow businesses, organizations, and other entities to obtain a prescription and to stock EAIs for use in an emergency if the business, organization or entity has employees, agents or others who are trained in recognition of anaphylaxis and the administration of EAIs. It would also provide liability protection to the business, organization, or entity that obtained the EAI and allow it to be used by a trained employee, agent, or other individual under certain circumstances. This bill does not mandate that an "authorized entity" participate in this voluntary program.
This bill seeks to create greater access to EAIs at locations where individuals could come into contact with allergens known to cause anaphylaxis in those persons with allergies.
Current Use of EAIs in California. SB 669 (Huff) Chapter 725, Statutes of 2013, authorized an off duty prehospital emergency medical care person or lay rescuer to use an EAI to render emergency care to another person. That bill required the EMS to establish and approve minimum standards for training in the use and administration of EAIs. In addition, EMS was required to approve the authorized training providers and determine the components to be included in the minimum training and requirements. In order to implement the training program required by SB 669, the EMS convened a work group of EMS stakeholders and subject matter experts to assist the EMS in the development of the training standards and the initial drafting of regulations to outline the training and certification process and requirements for a lay rescuer or off duty EMS personnel to obtain an EAI. The EMS concluded the regulatory process in October of 2015. Beginning January 1, 2016, the EMS can begin the process of reviewing and approving the required training programs to obtain the appropriate lay rescuer certification.
Other States. According to the author, in 2013 and 2014, Oregon, Florida, and Rhode Island passed legislation similar to what is included in this bill; in total there are 17 states that offer similar provisions for stockpiling EAIs outside of a school setting.
In 2013, President Obama signed into law the School Access to Emergency Epinephrine Act. The Act amends the Public Health Service Act, with respect to asthma-related grants for child health services, to give an additional preference to a state that allows self-administration of asthma and anaphylaxis medication (https://www.congress.gov/bill/113th-congress/senate-bill/1503/all-info). The Act requires elementary and secondary schools in such a state to: 1) permit trained personnel to administer epinephrine to a student reasonably believed to be having a reaction; 2) maintain a supply of epinephrine in a secure location that is easily accessible to trained personnel for such treatment; and, 3) have in place a plan for having on the school premises during operating hours one or more designated personnel trained in administration of epinephrine.
EAIs. According to one of the EAI's manufacturers' Web sites, there are two different doses of epinephrine available based on the weight of the individual. According to information provided by the American College of Allergy, Asthma and Immunology, common side effects of epinephrine may include anxiety, restlessness, dizziness, and shakiness. In addition, it was noted that after use of an EAI, it is recommended that an individual immediately visit a physician or an emergency room for medical treatment.
While EAIs appear to be commonly recommended as a method to treat specified anaphylactic conditions, EAIs are only available via a prescription from a licensed health care provider in the United States and cannot be purchased over-the-counter.
Analysis Prepared by: Elissa Silva / B. & P. / (916) 319-3301 FN: 0004364
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB |
THIRD READING
Bill No: AB 1386
:
SENATE HEALTH COMMITTEE: 7-0, 6/8/16
AYES: Hernandez, Nguyen, Mitchell, Monning, Nielsen, Pan, Roth
NO VOTE RECORDED: Hall, Wolk
SENATE JUDICIARY COMMITTEE: 7-0, 6/21/16
AYES: Jackson, Moorlach, Anderson, Hertzberg, Leno, Monning, Wieckowski
SENATE APPROPRIATIONS COMMITTEE: 7-0, 8/11/16
AYES: Lara, Bates, Beall, Hill, McGuire, Mendoza, Nielsen
ASSEMBLY FLOOR: 78-0, 1/27/16 (Consent) - See last page for vote
SOURCE: Allergy and Asthma Network
Mylan
DIGEST: This bill permits a health care provider to issue a prescription for, and a pharmacy to dispense, an epinephrine auto-injector to an authorized entity, which is defined as any entity or organization that employs at least one person that has completed an approved training course on the emergency use of epinephrine auto-injectors.
Existing law:
- Defines “epinephrine auto-injector” as a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
- Requires the Emergency Medical Services Authority (EMSA) to establish minimum standards for training and the use of epinephrine auto-injectors, and to approve authorized training providers. Requires the training requirements to include techniques for recognizing the signs and symptoms of anaphylaxis, as well as completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator, and specifies that the training certification is only valid for two years, after which recertification is required.
- Permits a pre-hospital emergency medical care person, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, if certain requirements are met, including that the epinephrine auto-injector is legally obtained by prescription, and that the person using the epinephrine auto-injector has a current certification of training issued by an authorized training provider.
- Permits a pharmacy to dispense epinephrine auto-injectors to a pre-hospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with specified requirements.
- Provides that a pre-hospital emergency medical care person, first responder, or lay rescuer who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his/her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards, except as specified.
- Permits a school district or county office of education to provide epinephrine auto-injectors to trained personnel, and permits trained personnel to utilize these epinephrine auto-injectors to provide emergency medical aid to persons suffering from an anaphylactic reaction.
This bill:
- Permits a health care provider to issue a prescription for an epinephrine auto-injector to an authorized entity, as defined by this bill, if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by EMSA.
- Revises the definition of “epinephrine auto-injector” to eliminate the reference to a spring-activated needle, and instead defines this term as a “disposable delivery device designed for automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.”
- Defines an “authorized entity,” for purposes of this bill, as any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course approved by EMSA for the emergency use of epinephrine auto-injectors, as specified in existing law.
- Requires an authorized entity that possesses and makes available epinephrine auto-injectors to create and maintain on its premises an operations plan that includes all of the following:
- The name and contact number for the health care provider who prescribed the epinephrine auto-injector;
- Where and how the epinephrine auto-injector will be stored;
- The names of the designated employees or agents who have completed the required training program and who are authorized to administer the epinephrine auto-injector;
- How and when the epinephrine auto-injector will be inspected for an expiration date; and,
- The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired or used epinephrine auto-injector in a sharps container.
- Requires an authorized entity that possesses and makes available epinephrine auto-injectors to submit to EMSA a report of each incident involving the use of an epinephrine auto-injector, within 30 days after each use. Requires EMSA to annually publish a report that summarizes all reports submitted to it under this bill.
- Permits a pharmacy to furnish epinephrine auto-injectors to an authorized entity, as defined by this bill, if both of the following requirements are met:
- The epinephrine auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity; and,
- An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished. Requires a new prescription to be written for any additional epinephrine auto-injectors required for use.
- Requires the pharmacy to label each epinephrine auto-injector dispensed pursuant to the provisions of this bill with all of the following: the name of the person or entity to whom the prescription was issued; the designations “Section 1797.197a Responder” and “First Aid Purposes Only;” and the dosage, use, and expiration date.
- Requires each epinephrine auto-injector prescription dispensed pursuant to the provisions of this bill to include the manufacturer’s product information sheet for the epinephrine auto-injector.
- Requires records regarding the acquisition and disposition of epinephrine auto-injectors to be maintained by the authorized entity for a period of three years from the date the records were created, and requires the authorized entity to be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
- Permits an epinephrine auto-injector dispensed pursuant to the provisions of this bill to be used only for the purpose, and under the circumstances, specified under existing law for emergency use of epinephrine auto-injectors.
- Provides authorized entities, as defined by this bill, with immunity from civil liability for damages resulting from any act or omission, other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents who is a lay rescuer, as defined. Prohibits the failure of an authorized entity to possess or administer an epinephrine auto-injector from resulting in civil liability.
- Provides an authorizing physician with immunity from civil liability, criminal prosecution, and professional review, for the issuance of a prescription for epinephrine auto-injectors pursuant to this bill unless the physician’s issues of the prescription constitutes gross negligence or willful or malicious conduct.
Comments
- Author’s statement. According to the author, food allergies, which can sometimes lead to a life-threatening allergic reaction, or anaphylaxis, are a large and growing public health problem. Today, an estimated one out of 13 children and one out of 20 adults in the U.S. has a food allergy, a considerably higher number than estimates only a few years ago. Additional children and adults who are allergic to insect stings and other factors can result in anaphylaxis. Anaphylaxis to food allergies results in approximately 90,000 emergency department visits each year in the U.S. Anaphylaxis results in approximately 1,500 deaths annually. This issue is serious and 47 states, including California, now have laws to allow or mandate schools to stock epinephrine auto-injectors. Schools are not the only place where children can come into contact with allergens capable of causing anaphylaxis. Greater access is needed to allow businesses, organization and other entities to stock epinephrine auto-injectors and allow for trained employees, agents and others to use those auto-injectors in an emergency. This bill expands access and allows day care, colleges and universities, summer and day camps, restaurants, sports arenas, sports leagues, scout troops, before and after school programs, recreational parks and other places where children and adults could come into contact with potentially life-threatening allergens to stock epinephrine auto-injectors and be better prepared in the event of an emergency. It does not require any entity to stock epinephrine auto-injectors, but simply allows it.
- What is anaphylaxis? According to the National Institutes of Health, anaphylaxis is a severe, whole-body allergic reaction to a chemical that has become an allergen. After being exposed to a substance such as bee sting venom, the person's immune system becomes sensitized to it. When the person is exposed to that allergen again, an allergic reaction may occur. Anaphylaxis happens quickly after the exposure, is severe, and involves the whole body. Tissues in different parts of the body release histamine and other substances. This causes the airways to tighten and leads to other symptoms. Some drugs (morphine, x-ray dye, aspirin, and others) may cause an anaphylactic-like reaction (anaphylactoid reaction) when people are first exposed to them. These reactions are not the same as the immune system response that occurs with "true" anaphylaxis. However, the symptoms, risk for complications, and treatment are the same for both types of reactions. Anaphylaxis can occur in response to any allergen. Anaphylaxis is life-threatening and can occur at any time. Risks include a history of any type of allergic reaction.
- What is an epinephrine auto-injector? An epinephrine auto-injector is a medical device used to deliver a measured dose of epinephrine (also known as adrenaline) using auto-injector technology, most frequently for the treatment of acute allergic reactions to avoid or treat the onset of anaphylaxis. The EpiPen (and the version for smaller children, the EpiPen Jr.) are commonly used epinephrine auto-injectors. According to Mylan, which makes the EpiPen and EpiPen Jr., the EpiPen contains 0.3mg of epinephrine and is intended for those who weigh 66 pounds or more, while the EpiPen Jr. contains 0.15mg, and is intended for patients weighing between 33 to 66 pounds. Mylan’s product information states that it is not known if EpiPen and EpiPen Jr. are safe and effective in children who weigh less than 33 pounds. The devices are intended to be injected into the middle of the outer thigh, and patients are directed not to inject the device into a vein, buttock, fingers, toes, hands or feet.
FISCAL EFFECT: Appropriation: Fiscal Com.: Local:
According to the Senate Appropriations Committee:
- One-time costs of $50,000 for the development of information technology systems to track information relating to the issuance of certificates and collection of data on usage of epinephrine auto-injectors under this bill by the EMSA (General Fund).
- One-time costs of $130,000 over two years for the adoption of regulations by the EMSA (General Fund).
- Ongoing costs of $90,000 per year to review training programs, issue certificates to participating individuals, and report data on the program by the EMSA (General Fund).
Allergy and Asthma Network (co-source)
Mylan (co-source)
American Latex Allergy Association
American Red Cross
California Chapter of the American College of Emergency Physicians
California Retailers Association
California Society of Allergy, Asthma and Immunology
Food Allergy Research and Education
SF Bay Area Food Allergy Network
Two individuals
OPPOSITION: (Verified 8/13/16)
None received
ARGUMENTS IN SUPPORT: This bill is co-sponsored by Mylan and the Allergy and Asthma Network. Mylan, which is a manufacturer of generic and specialty medications, including epinephrine auto-injectors, states in support that while California has made great strides to address anaphylaxis-related tragedies, more can be done to ensure the state is better prepared. Mylan states that this bill builds upon California’s current school access law and expand access to this critical medication. The Allergy and Asthma Network (Network) states in support that venues that wish to stock epinephrine will ensure staff is trained to identify and respond to life-threatening anaphylactic reactions. According to the Network, the data shows that death from anaphylaxis occurs more often when the individual is away from home and there is either a delay before epinephrine is administered or it is not given at all. The American Red Cross also support this bill, stating that this bill strives to protect the millions of Californians who are at risk for anaphylactic shock, and will also protect the businesses that obtain a prescription for epinephrine with liability protection. The California Retailers Association states in support that this bill sets sufficient training requirements for employees and volunteers and establishes a detailed tracking process for when epinephrine auto-injectors are used. The California Chapter of the American College of Emergency Physicians states that this bill will save lives by increasing the availability of epinephrine auto-injectors and the training for their use by lay persons. The American Latex Allergy Association states that one in 13 children and one in 20 adults has a food allergy, additionally, others have insect and other non-food allergies that trigger anaphylactic shock, and that epinephrine auto-injectors are crucial for treating anaphylaxis. The SF Bay Area Food Allergy Network states that while legislation providing epinephrine auto-injectors in schools was a great step forward, there is no such measure available to day care centers and preschools, and this bill will give them the ability to be better prepared to respond in an allergic emergency.
ASSEMBLY FLOOR: 78-0, 1/27/16
AYES: Achadjian, Alejo, Travis Allen, Baker, Bigelow, Bloom, Bonilla, Bonta, Brough, Brown, Burke, Calderon, Campos, Chang, Chau, Chávez, Chiu, Chu, Cooley, Cooper, Dababneh, Dahle, Daly, Dodd, Eggman, Frazier, Beth Gaines, Gallagher, Cristina Garcia, Eduardo Garcia, Gatto, Gipson, Gomez, Gonzalez, Gordon, Gray, Grove, Hadley, Harper, Roger Hernández, Holden, Irwin, Jones, Jones-Sawyer, Kim, Lackey, Levine, Linder, Lopez, Low, Maienschein, Mayes, McCarty, Medina, Melendez, Mullin, Nazarian, Obernolte, O'Donnell, Olsen, Patterson, Quirk, Rendon, Ridley-Thomas, Rodriguez, Salas, Santiago, Steinorth, Mark Stone, Thurmond, Ting, Wagner, Waldron, Weber, Wilk, Williams, Wood, Atkins
NO VOTE RECORDED: Mathis
8/15/16 20:10:03
**** END ****
SENATE COMMITTEE ON APPROPRIATIONS
Senator Ricardo Lara, Chair
2015 - 2016 Regular Session
AB 1386 (Low) - Emergency medical care: epinephrine auto-injectors
Version: June 28, 2016 | Policy Vote: HEALTH 7 - 0, JUD. 7 - 0 |
Urgency: No | Mandate: Yes |
Hearing Date: August 1, 2016 | Consultant: Brendan McCarthy |
This bill meets the criteria for referral to the Suspense File.
Bill Summary:
AB 1386 would allow a health care provider to issue a prescription for an epinephrine auto-injector to an authorized entity. The bill would authorize a pharmacy to fill such a prescription.
Fiscal Impact:
- One-time costs of $50,000 for the development of information technology systems to track information relating to the issuance of certificates and collection of data on usage of epinephrine auto-injectors under the bill by the Emergency Medical Services Authority (General Fund).
- One-time costs of $130,000 over two years for the adoption of regulations by the Emergency Medical Services Authority (General Fund).
- Ongoing costs of $90,000 per year to review training programs, issue certificates to participating individuals, and report data on the program by the Emergency Medical Services Authority (General Fund).
Background:
Under current law, the Emergency Medical Services Authority develops guidelines and standards for emergency medical systems, including standards for training and the scope of practice for emergency medical personnel.
Under current law, school districts and county offices of education are authorized to designate school personnel to receive training to use an epinephrine auto-injector to render emergency medical care under certain conditions. In addition, current law authorizes prehospital emergency medical personnel, first responders, or lay rescuers to use an epinephrine auto-injector to render emergency medical care, if certain conditions are met, including training requirements.
Proposed Law:
AB 1386 would allow a health care provider to issue a prescription for an epinephrine auto-injector to an authorized entity. The bill would authorize a pharmacy to fill such a prescription.
Specific provisions of the bill would:
- Authorize a health care provider to issue a prescription for an epinephrine auto-injector to an authorized entity, if certain conditions are met;
- Authorize a pharmacy to fill such a prescription;
- Define authorized entity to include any for-profit, nonprofit, or government entity or organization that employs one person or utilizes a volunteer or agent that has completed a required training course;
- Place certain requirements on an authorized entity, including a requirement to report any use of an epinephrine auto-injector to the Emergency Medical Services Authority;
- Require the Authority to report annually on the use of epinephrine auto injectors under the bill;
- Provide limited immunity from professional review, civil liability or criminal prosecution for prescribers or authorized entities.
Related Legislation:
- SB 738 (Huff, Statutes of 2015) provides qualified immunity to a physician who prescribes an epinephrine auto-injector to a school district or related entity.
- SB 1266 (Huff, Statutes of 2014) requires school districts and related entities to provide epinephrine auto-injectors to school nurses or trained volunteers.
- SB 669 (Huff, Statutes of 2013) authorizes prehospital emergency medical care personnel, first responders, and lay rescuers to use an epinephrine auto-injector
Staff Comments:
Current law authorizes the Authority to charge fees for approval of training courses ($500) and individual certification cards ($15). Applicants under this bill would be required to pay those fees as well. However, it is not expected that enough of either type of applicant will apply to generate sufficient fee revenues to offset the additional costs imposed by the bill.
The only costs that may be incurred by a local agency relate to crimes and infractions. Under the California Constitution, such costs are not reimbursable by the state.
-- END --
Senator Hannah-Beth Jackson, Chair
2015-2016 Regular Session
Bill No: AB 1386 (Author:Low)
Version: June 13, 2016
Hearing Date: June 21, 2016
Fiscal: Yes
Urgency: No
Consultant: RD
SUBJECT
Emergency medical care: epinephrine auto-injectors
DESCRIPTION
This bill would allow “authorized entities,” as defined to include both private and government entities, to obtain epinephrine auto-injectors for the use of any one of their employees, volunteers, or agents, who is a lay rescuer, as specified, to render emergency care to another person. This bill would further ensure, however, that the failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability. Additionally, this bill would apply an existing qualified immunity for physicians and surgeons who write prescriptions for epinephrine auto-injectors for use in schools to physicians and surgeons who write prescriptions to prehospital medical care persons, laypersons, or for use of qualifying employees, volunteers, or agents of authorized entities. Lastly, this bill would also authorize pharmacies to furnish prescriptions to authorized entities for these purposes, as specified, and would otherwise revise existing requirements and standards under the Health and Safety Code relating to the administration of epinephrine auto-injectors by Good Samaritans in emergencies.
BACKGROUND
An epinephrine auto-injector is a disposable medical drug delivery device that delivers a single measured dose of epinephrine, most frequently for the treatment of acute allergic reactions to avoid or treat the onset of anaphylactic shock. Anaphylactic shock can quickly result in death if untreated. Epinephrine auto-injectors can be obtained by prescription only, and California law does not authorize non-physicians to administer an epinephrine auto-injector to another person, except in limited circumstances.
Over the years, California law has been amended to permit school districts or county offices of education to provide emergency epinephrine auto-injectors to trained personnel, and to permit trained personnel to utilize the auto-injectors to provide emergency medical aid to persons suffering from an anaphylactic reaction, as it is not uncommon for children to come into contact with specific allergens (such as bee stings) or accidentally ingest foods they are allergic to at school. (See AB 559 (Wiggins, Ch. 458, Stats. 2001); see also SB 1266 (Huff, Ch. 321, Stats. 2014), which was subsequently enacted to require, as opposed to simply authorize, school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors to voluntary, trained personnel who, consistent with existing law, may use the auto-injectors to provide emergency medical aid to persons suffering from an anaphylactic reaction.)
More recently, in 2013, California law was expanded to also permit certain Good Samaritans (specifically, prehospital emergency medical care persons or lay rescuers), to obtain and administer epinephrine auto-injectors to provide emergency medical aid to persons suffering from anaphylactic shock. (SB 669 (Huff, Ch. 725, Stats. 2013).) In doing so, the legislation granted such individuals, acting in good faith and not for compensation, immunity for any civil damages resulting from any acts or omissions in administering the auto-injector to a person who appears to be experiencing anaphylaxis at the scene of an emergency, as long as the person did not act with gross negligence or willful or wanton misconduct and otherwise complies with certain requirements and standards, including training requirements.
Of import to this bill, just this last year, SB 738 (Huff, Ch. 132, Stats. 2015) was brought to address an issue of concern for doctors who are needed to write these prescriptions so that schools may obtain and stock epinephrine auto-injectors as required by these bills. The proponents of SB 738 reported that schools were having difficulty obtaining epinephrine auto-injectors because doctors were declining to write those prescriptions out of fear of both professional disciplinary action and both civil and criminal liability from any resulting acts or omissions in relation to the administration of the prescribed auto-injector in an emergency. While these types of Good Samaritan laws have largely stopped short (intentionally so) of providing immunity to individuals for negligent acts or omissions in the performance of their professional duties, it has also become clear that doctors, in their ordinary practice of medicine, do not and cannot prescribe medication to third persons. Accordingly, SB 738 was enacted to grant any physician or surgeon issuing a prescription or order for these purposes immunity from any potential civil or criminal liability or from professional disciplinary action, unless the physician and surgeon’s issuance constitutes gross negligence or willful or malicious conduct.
This bill would now add authorization for other “authorized entities” to obtain epinephrine auto-injectors so that any employees, volunteers, or agents of the entity who otherwise meet the existing definition of “lay rescuer” could render emergency care to a person who appears to be suffering from anaphylaxis in accordance with existing law for lay rescuers. This bill would extend the existing qualified immunity for physicians and surgeons to physicians and surgeons who write prescriptions to prehospital medical care persons, laypersons, or for use of qualifying employees, volunteers, or agents of authorized entities, in accordance with specified law.
CHANGES TO EXISTING LAW
- Existing law requires school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered, as specified, and provides that school nurses or trained personnel may use epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction. (Ed. Code Sec. 49414(a).) Existing law provides for the defense and indemnification of any employees who volunteer under this law, from any and all civil liability, in accordance with, but not limited to, the Government Tort Claims Act, as specified. (Ed. Code Sec. 49414(j).)
Existing law provides that an authorizing physician and surgeon shall not be subject to professional review, be liable in a civil action, or be subject to criminal prosecution for the issuance of a prescription or order, for the above purposes, unless the physician and surgeon’s issuance of the prescription or order constitutes gross negligence or willful or malicious conduct. (Ed. Code Sec. 49414(g)(4).)
Existing law provides that any prehospital emergency medical care person or lay rescuer who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if that person has complied with the requirements and standards of Section 1797.197a of Health and Safety Code, below. This protection from civil liability does not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector. (Civ. Code Sec. 1714.23(b), (c).)
This bill would add to the Civil Code that an authorized entity shall not be liable for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents, who is a lay rescuer as defined under existing law. This bill would further provide that the failure of an authorized entity to possess or administer an epinephrine auto-injector shall not result in civil liability.
This bill would provide the proposed qualified immunity for authorized entities, and the existing qualified immunity for prehospital emergency medical care person or lay rescuers, shall not affect any other immunity or defense available under law.
This bill would add that an authorizing physician and surgeon is not subject to professional review, liable in a civil action, or subject to criminal prosecution for the issuance of a prescription or order pursuant to this section, unless the issuance of the prescription or order constitutes gross negligence or willful or malicious conduct.
- Existing law, Section 1797.197a of the Health and Safety Code, requires the Emergency Medical Services authority (EMSA) to establish and approve the authorized training providers and minimum standards for training and the use and administration of epinephrine auto-injectors, as specified. The minimum training and requirements must include, among other things:
- techniques for recognizing circumstances, signs, and symptoms of anaphylaxis;
- standards and procedures for proper storage and emergency use of epinephrine auto-injectors; and
- specified emergency follow up procedures (e.g., calling 9-1-1). (Health & Saf. Code Sec. 1797.197a(c).)
Existing law authorizes a prehospital emergency medical care person or lay rescuer to use an epinephrine auto-injector to render emergency care to another person if specified requirements are met. The requirements include, among other things, that:
- the auto-injector is legally obtained by prescription from an authorized health care provider, as specified;
- the auto-injector is used on another, with the express or implied consent of that person, for the purpose of treating anaphylaxis;
- the person using the auto-injector has successfully completed a training course, as specified and has current certification of training issued by the training provider; and
- the auto-injectors obtained by prehospital emergency medical care personnel from a pharmacy, as authorized by law, are used only when functioning outside the course of the person’s occupational duties, or as a volunteer. (Health & Saf. Code Sec. 1797.197a(b).)
Existing law permits an authorized health care provider to issue a prescription for an epinephrine auto-injector to a prehospital emergency medical care person or lay rescuer for the purpose of rendering emergency care to another person, upon presentation of current certification demonstrating that person is trained and qualified to administer an epinephrine auto-injector, as specified. (Health & Saf. Code Sec. 1797.197a(b)(1).)
This bill would, instead, authorize a prehospital medical care person or lay rescuer to use an epinephrine auto-injector to render emergency care to another person if, among other things, the epinephrine auto-injector is legally obtained by prescription from an authorized health care provider or from an authorized entity that acquired the epinephrine auto-injector, as specified, below.
This bill would permit an authorized health care provider to issue a prescription for an epinephrine auto-injector to a prehospital emergency medical care person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current epinephrine auto-injector certification card issued by the EMSA demonstrating that the person is trained and qualified to administer an epinephrine auto-injector, as specified.
This bill would similarly permit an authorized health care provider to issue a prescription for an epinephrine auto-injector to an authorized entity if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by the EMSA demonstrating that the person is qualified to administer an epinephrine auto-injector, as specified.
This bill would require a participating authorized entity to:
- create and maintain on its premises an operations plan that includes, among other things:
- the names of the designated employees or agents who have completed the required training program, and who are authorized to administer the auto-injector; and
- how and when the auto-injector will be inspected for an expiration date; and
- submit to the EMSA, as specified, a report of each incident that involves the use of an epinephrine auto-injector, not more than 30 days after each use. The EMSA must, in turn, annually publish a report that summarizes all such reports.
This bill would define “authorized entity” to mean any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course, as required.
- Existing law authorizes a pharmacy, notwithstanding any other provision of law, to furnish epinephrine auto-injectors to a school district, county office of education, or charter school pursuant to specified law, if:
- the auto-injectors are furnished exclusively for use at a school district site or county office of education; and
- a physician and surgeon provides a written order that specifies the quantity of auto-injectors to be furnished. (Bus. & Prof. Code Sec. 4119.2(a).)
Existing law requires a school district, county office of education, or charter school to keep certain records of epinephrine auto-injectors furnished pursuant to the law, above, and makes the entities responsible for monitoring the supply of auto-injectors and ensuring the destruction of expired auto-injectors. (Bus. & Prof. Code Sec. 4119.2(b).)
Existing law authorizes a pharmacy, notwithstanding any other law, to dispense epinephrine auto-injectors to a prehospital emergency medical care person or lay rescuer for the purpose of rendering emergency care, in accordance with Section 1797.197a, above, if:
- A physician and surgeon provides a written order that specifies the quantity of auto-injectors to be dispensed by a prehospital emergency medical care person or lay rescuer, as specified. The prescription may be issued only upon presentation of a current certificate demonstrating that the person is trained and qualified, as specified, to administer an auto-injector to another person in an emergency. The prescription must state certain information and a new prescription is required for any additional auto-injectors.
- The pharmacy must label each auto-injector dispensed with certain information, including the designations “Section 1797.197a Responder” and “First Aid Purposes Only.” (Bus. & Prof. Code Sec. 4119.3(a).)
Existing law requires a prehospital emergency medical care person or lay person receiving epinephrine auto-injectors pursuant to the above to make and maintain certain records, as specified, including as to the circumstances and manner of destruction of any auto-injectors. (Bus. & Prof. Code Sec. 4119.3(b).)
Existing law specifies that the epinephrine auto-injectors dispensed to prehospital emergency medical care persons or lay rescuers pursuant to the above, may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code. (Bus. & Prof. Code Sec. 4119.3(c).)
This bill would authorize a pharmacy, notwithstanding any other law, to furnish epinephrine auto-injectors to an “authorized entity” if:
- the auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity; and
- an authorized health care provider provides a prescription that specifies the quantity of auto-injectors to be furnished. The pharmacy must label each auto-injector dispensed with certain information, such as: the name of the person or entity to whom the prescription was issued, and the designations “Section 1797.197a Responder” and “First Aid Purposes Only.”
This bill would require that the authorized entity maintain certain records of epinephrine auto-injectors furnished to them in accordance with the above, and would provide that the authorized entity shall be responsible for monitoring the supply and the destruction of expired epinephrine auto-injectors.
This bill would specify that the epinephrine auto-injector dispensed to authorized entities pursuant to the above, may be used only for the purpose, and under the circumstances, described in Section 1797.197a of the Health and Safety Code.
- Existing law provides that an “epinephrine auto-injector” means a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis. (Civ. Code Sec. 1714.23(a)(2); Health & Saf. Code Sec. 1797.197a(a)(1)(2), Educ. Code Sec. 49414(b)(3).)
This bill would, instead, define “epinephrine auto-injector” to mean a disposable delivery device designed for the automatic injection of a premeasured dose of epinephrine into the human body to prevent or treat a life-threatening allergic reaction.
This bill would make other technical and non-substantive changes.
COMMENT
1. Stated need for the bill
According to the author:
Allergies to food, insect stings and other substances that can cause anaphylaxis are increasing. There are approximately 90,000 emergency room visits and an estimated 1,500 deaths a year from anaphylaxis in the United States. This legislation would allow for greater access of epinephrine auto-injectors at locations where individuals could come into contact with allergens known to cause anaphylaxis in those with allergies. While existing law allows individuals who have been trained in recognition of symptoms of allergic reactions and anaphylaxis to administer epinephrine auto-injectors to others in an emergency and provides liability protection for these individuals, current law does not allow the business, group or entity that the individual is employed by or associated with to obtain a prescription for an epinephrine auto-injector or to have liability protection if the epinephrine auto-injector is used on the entities premises.
2. Qualified immunity for authorized entities
As a general rule, California law provides that everyone is responsible, not only for the result of his or her willful acts, but also for an injury occasioned to another by his or her want of ordinary care or skill in the management of his or her property or person, except so far as the latter has, willfully or by want of ordinary care, brought the injury upon himself or herself. (Civ. Code Sec. 1714(a).) Although immunity provisions are rarely preferable because they, by their nature, prevent an injured party from seeking a particular type of recovery, the Legislature has in limited scenarios approved limited immunity from liability (as opposed to blanket immunities) to promote other policy goals that could benefit the public. Along these lines, this Legislature has on multiple occasions, enacted legislation that encourages the use of life saving medications or medical interventions (such as automatic external defibrillators (AEDs), epinephrine auto-injectors (epi-pens), and opioid antagonists) in order to avoid preventable deaths by limiting the liability of “Good Samaritans,” as long as certain minimal requirements are met. In most of those scenarios, however, the qualified immunity does not apply in the case of personal injury or wrongful death which results from the gross negligence or willful or wanton misconduct by the person who renders the care. (See Civ. Code Sec. 1714.21.)
With respect to epi-pens, specifically, as noted in the Background, California law already encourages the use of this life-saving medication to avoid preventable deaths in both schools and in the general public. Recognizing that public employees (in particular, school nurses) already enjoy liability protections under the Government Tort Claims Act, existing law requires that schools provide defense and indemnification to employees who volunteer for training to administer epi-pens in emergency situations from any and all civil liability, in accordance with, but not limited to, that Act. (See Ed. Code Sec 49414.) Separately, the Civil Code provides certain Good Samaritans—namely, prehospital emergency care persons and lay persons, as defined—acting in good faith and not for compensation, qualified immunity from civil damages for any of their acts or omissions in administering the epi-pen to a person who appears to be suffering from anaphylaxis at the scene of emergency, if the person complies with certain requirements and standards, including training requirements. As mentioned above, this immunity is, however, qualified (i.e., limited), insofar as it does not apply to protect the person from civil damages in any personal injury or wrongful death case involving gross negligence or willful or wanton misconduct in rendering emergency care treatment by use of the auto-injector.
This bill would now add similar protection from civil liability for authorized entities that choose to obtain epinephrine for use by their employees, volunteers, or agents, who otherwise meet the existing definition of “lay rescuer” to render emergency care to a person who appears to be suffering from anaphylaxis in accordance with existing law requirements for lay rescuers. In other words, these individuals would otherwise have to be trained and comply with any other standards of requirements that would apply to other lay rescuers in order to be subject to the existing qualified immunity when administering an epi-pen to render emergency medical care to a person who appears to be suffering from anaphylaxis. Notably, for these purposes, authorized entities include not only nonprofit or for profit private entities or organizations, but also government entities or organizations. Presumably, government entities are already significantly protected from liability under the Government Tort Claims Act. To the extent that this bill creates any new liability protections, however, for nonprofit and for profit entities that obtain epi-pens for such emergency use, or even for government entities, that immunity is also qualified and would not apply where there has been gross negligence or willful or wanton misconduct in connection with the administration of the epi-pen.
In support, sponsor Mylan cites that nearly 6 million or 8 percent of children in the U.S. have food allergies—approximately 1 in 13. Food allergens account for 30 percent of fatal cases of anaphylaxis, of which there are approximately 1,500, annually. Mylan writes that “California has made great strides to address this issue, but more can be done to ensure that the state is better prepared in the event that children or adults experience an anaphylactic reaction for the first time or in a public location. Schools were a very important first step in addressing anaphylaxis. This legislation will build upon California’s current school access law and expand access to this critical medication. This legislation would expand access to allow colleges and universities, churches, summer camps, sports arenas, restaurants, recreational parks and other places where children and adults could come into contact with potentially life-threatening allergens to stock epinephrine auto-injectors and allow trained personnel to administer them in emergencies.” Staff notes, in the years since passing legislation encouraging the stocking and application of epi-pens for emergency use by both schools and trained individuals, the Committee has not received direct reports or anecdotes of any harm that has resulted from the availability and application of the medication by school volunteers, lay rescuers, or prehospital emergency care persons.
3. Suggested amendments to further clarify and narrow the qualified immunity
As discussed above, this bill ensures that an authorized entity is not rendered immune from any acts or omissions of its employees, volunteers, or agents that constitute gross negligence or willful or wanton misconduct connected to the administration of the auto-injector. Staff notes, however, that the bill’s qualified immunity for authorized entities should also be made contingent upon meeting the statutory requirements imposed on these authorized entities under the Health and Safety Code. Specifically, this bill would revise Section 1797.197a of the Health and Safety Code to require an authorized entity that possesses and makes available epinephrine auto-injectors to create and maintain, on its premises, a specified operations plan that includes, for example: where and how the auto-injector will be stored; the names of the designated employees or agents who have completed the required training program under existing law, and who are authorized to administer the injector; and how and when the auto-injector will be inspected for an expiration date. Furthermore, under that section, the entity would also have to submit a report of each incident that involves the use of an epinephrine auto-injector to the state Emergency Medical Services authority. And, notably, this particular statute (again, as to be amended by the bill) recognizes that the entity must submit evidence that it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by the authority demonstrating that the person is qualified to administer an epinephrine auto-injector, as specified, in order to receive a prescription from a physician.
Accordingly, the author has agreed to the following amendment to ensure that the entity has complied with its duties under the Health and Safety Code as a threshold matter, in order to enjoy any immunity for any negligent acts or omissions of its qualifying employees, volunteers, or agents in connection to their administration of the auto-injector:
Suggested amendment:
On page 5, line 7, add to the end of the sentence: “, if the entity has complied with all applicable requirements of Section 1797.197a of the Health and Safety Code.”
Additionally, because the proposed civil immunity for authorized entities would expressly disallow application of that immunity where there has been gross negligence or willful or wanton misconduct on part of the entity’s employee, volunteer or agent in the administration of an epinephrine auto-injector, to avoid confusion the author has also agreed to the following technical amendment to limit the application of the current exception for gross negligence or willful or wanton misconduct to the provision providing immunity for prehospital emergency care persons and lay persons.
Technical amendment:
On page 5, line 12, amend subdivision (c) of Section 1714.23 of the Civil Code to read: “The protection specified in paragraph (1) of subdivision (b) shall not apply in a case of personal injury or wrongful death that results from the gross negligence or willful or wanton misconduct of the person who renders emergency care treatment by the use of an epinephrine auto-injector.”
4. Qualified immunity for physicians
As recently amended by the author, in part due to opposition concerns, this bill seeks to provide immunity for doctors who write a prescription for epinephrine auto-injectors to an authorized entity, or to a lay person or prehospital emergency medical care person, for purposes of rendering emergency care to another person who appears to be suffering from anaphylaxis. With respect to the doctors who are relied upon to write the prescription or orders for the medication or medical device, similar liability protection has been provided in both the AED and opioid antagonist context. Most recently, it was also applied in the epi-pen context, but only insofar as the prescription was for a school. As discussed in the Background, just last year, SB 738 (Huff, Ch. 132, Stats. 2015) added a similar provision in law for physicians and surgeons who issue prescriptions or orders for epi-pens to schools, in furtherance of existing California law that requires schools to provide emergency epinephrine auto-injectors to trained personnel who may use the auto-injectors to provide emergency medical aid to persons suffering from anaphylactic reaction. That provision was based, in part, upon those provisions already in place with respect to AEDs and naloxone.
For example, existing law provides physicians who are involved with the placement of an AED protection against any civil liability for any civil damages resulting from any acts or omissions of a person who renders emergency care using that AED, if that physician, person, or entity has complied with existing law requirements. That law also provides that any limited liability protection does not apply in the case of personal injury or wrongful death which results from the gross negligence or willful or wanton misconduct of the person who renders emergency care or treatment by the use of an AED. (See Civ. Code Sec. 1714.21.) Separately, in 2013, AB 635 (Ammiano, Ch. 707, Stats. 2013) was enacted to provide that a licensed health care provider who acts with reasonable care shall not be subject to professional review, found liable in a civil action, or be subject to criminal prosecution for issuing a prescription or standing order for an opioid antagonist to a person at risk of an opioid-related overdose or to a family member, friend, or other person in a position to assist a person at risk of an opioid-related overdose, as specified. (See Civ. Code Sec. 1714.22.)
This bill, modeled upon last year’s SB 738, would expand the existing physicians’ immunity in the epi-pen context to ensure that an authorizing physician and surgeon will also not be subject to professional review, liable in a civil action, or subject to criminal prosecution for the issuance of a prescription or order to a prehospital emergency medical care person, lay person, or authorized entity, as specified, unless the issuance constitutes gross negligence or willful or malicious conduct. In doing so, the bill would not only be consistent with SB 738, but it would arguably further the original intent of SB 669 (Huff, Ch. 725, Stats. 2013) to ensure that trained personnel and Good Samaritans, acting in good faith and not for compensation, have epi-pens available for the emergency treatment of individuals suffering from anaphylactic shock, in order to avoid preventable deaths.
Additionally, the author has agreed to the following amendment to further ensure that the physician and surgeon has prescribed the epi-pen in accordance with the Health and Safety Code, which, under this bill, would authorize providers to issue a prescription to a prehospital emergency medical care person, lay rescuer, or authorized entity, upon the presentation of a specified certification card demonstrating that the person or the entity’s employee, agent, or volunteer is trained and qualified to administer an epinephrine auto-injector in accordance with specified law. (Emphasis added.)
Suggested amendment
On page 5, line 23, strike “pursuant to this section” and insert “and in accordance with Section 1797.197a of the Health and Safety Code”
5. Other clarifying amendments
This bill permits pharmacies to furnish epinephrine auto-injectors to authorized entities for the purpose of rendering emergency care in accordance with specified Health and Safety Code standards, as long as: (1) a physician and surgeon provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished; and (2) the epinephrine auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity. Staff notes, however, that in a parallel statute authorizing a pharmacy to dispense an epinephrine auto-injector to lay rescuers and prehospital emergency medical persons, existing law additionally specifies that the physician and surgeon may issue the underlying prescription only upon presentation of a current certificate demonstrating that the person is trained and qualified under Section 1797.197a of the Health and Safety Code to administer an epinephrine auto-injector to another person in an emergency situation. (See Bus. & Prof. Code Sec. 4119.3.) By way of another example, under existing law, the epi-pen must not only specify that the dispensed epinephrine auto-injector is for “First Aid Purposes Only” and that the named recipient is a “Section 1797.197a Responder”(which this bill would similarly require), but also, a new prescription must be written for any additional epinephrine auto-injectors required (which this bill does not expressly require). The following amendments will add further consistency between the existing provisions governing pharmacies that dispense epi-pens to a prehospital medical care person or lay person and the bill’s correlating provision for authorized entities.
Suggested amendments:
On page 3, lines 10-11, after “the quantity of epinephrine auto-injectors to be furnished” insert “to an authorized entity described in subdivision (a) of Section 1797.197a of the Health and Safety Code. A new prescription shall be written for any additional epinephrine auto-injectors required.”
On page 3, lines 3-6, amend proposed Section 4119.4 of the Business and Professions Code to read: “Notwithstanding any other law, a pharmacy may furnish epinephrine auto-injectors to an authorized entity, as defined by Section 1979.197a of the Health and Safety Code, for the purpose of rendering emergency care in accordance with Section 1797.197a of the Health and Safety Code, if both of the following are met:”
6. Removal of opposition
Staff notes that the organizations previously registered in opposition to this bill have since removed their opposition based on the June 13, 2016, version of the bill, which added a qualified immunity for physicians. Those groups, the Allergy & Asthma Network, California Society of Allergy, Asthma and Immunology, and Food Allergy Research & Education, are now in support of the bill.
Support: Allergy & Asthma Network; Allergy Station @ SacENT; American Latex Allergy Association; American Red Cross; California Society of Allergy, Asthma and Immunology; California Chapter of the American College of Emergency Physicians; California Retailers Association; Food Allergy Research & Education; SF Bay Area Food Allergy Network; two individuals
Opposition: None Known
HISTORY
Source: Mylan
Related Pending Legislation:
AB 1748 (Mayes, 2016) would, among other things, authorize school nurses or, if the school does not have a school nurse, a person who has received training regarding opioid antagonists, as specified, to immediately administer the medication under certain circumstances. The bill would provide for various immunities, as specified.
AB 1719 (Rodriguez, 2016) would provide for various immunities relating to the instruction of students in compression-only CPR or use of an AED.
Prior Legislation:
SB 738 (Huff, Ch. 132, Stats. 2015) See Background.
SB 1266 (Huff, Ch. 321, Stats. 2014) See Background.
SB 669 (Huff, Ch. 725, Stats. 2013) See Background.
SB 635 (Ammiano, Ch. 707, Stats. 2013) See Comment 2.
SB 161 (Huff, Ch. 560, Stats. 2011) authorized a school district, county office of education, or charter school to participate in a program to provide nonmedical school employees with voluntary emergency medical training to provide, in the absence of an onsite credentialed school nurse or other licensed nurse, emergency medical assistance to pupils with epilepsy suffering from seizures, in accordance with specified guidelines. SB 161 provided volunteers with defense and indemnification by the school district, county office of education, or charter school, for any and all civil liability, as specified.
AB 559 (Wiggins, Ch. 458, Stats. 2001) See Background.
AB 1791 (Wiggins, 1999) was similar to AB 559, above, but was ultimately vetoed.
Prior Vote:
Senate Health Committee (Ayes 7, Noes 0)
Assembly Floor (Ayes 78, Noes 0)
Assembly Appropriations Committee (Ayes 17, Noes 0)
Assembly Judiciary Committee (Ayes 9, Noes 0)
Assembly Business and Professions Committee (Ayes 14, Noes 0)
Assembly Rules Committee (Ayes 10, Noes 0)
**************
SENATE COMMITTEE ON HEALTH
Senator Ed Hernandez, O.D., Chair
BILL NO: AB 1386
AUTHOR: | Low | ||
VERSION: | May 31, 2016 | ||
HEARING DATE: | June 8, 2016 | ||
CONSULTANT: | Vince Marchand | ||
SUBJECT: Emergency medical care: epinephrine auto-injectors
SUMMARY:
Permits a health care provider to issue a prescription for, and a pharmacy to dispense, an epinephrine auto-injector to an authorized entity, which is defined as any entity or organization that employs at least one person that has completed an approved training course on the emergency use of epinephrine auto-injector.
Existing law:
- Defines “epinephrine auto-injector” as a disposable drug delivery system with a spring-activated concealed needle that is designed for emergency administration of epinephrine to provide rapid, convenient first aid for persons suffering from anaphylaxis.
- Defines “lay rescuer” as any person who has met the training standards and other requirements of existing law relating to the emergency use of epinephrine auto-injectors but who is not otherwise licensed or certified to use an epinephrine auto-injector on another person.
- Requires the Emergency Medical Services Authority (EMSA) to establish minimum standards for training and the use of epinephrine auto-injectors, and to approve authorized training providers. Requires the training requirements to include techniques for recognizing the signs and symptoms of anaphylaxis, as well as completion of a training course in cardiopulmonary resuscitation and the use of an automatic external defibrillator, and specifies that the training certification is only valid for two years, after which recertification is required.
- Permits a pre-hospital emergency medical care person, or lay rescuer to use an epinephrine auto-injector to render emergency care to another person, if certain requirements are met, including that the epinephrine auto-injector is legally obtained by prescription, and that the person using the epinephrine auto-injector has a current certification of training issued by an authorized training provider.
- Permits a pharmacy to dispense epinephrine auto-injectors to a pre-hospital emergency medical care person, first responder, or lay rescuer for the purpose of rendering emergency care in accordance with specified requirements.
- Requires epinephrine auto-injectors obtained by pre-hospital emergency medical care personnel to be used only when functioning outside the course of the person’s occupational duties, or as a volunteer, as specified.
- Provides that a pre-hospital emergency medical care person, first responder, or lay rescuer who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency situation is not liable for any civil damages resulting from his/her acts or omissions in administering the epinephrine auto-injector, if that person has complied with specified certification and training requirements and standards, except as specified.
- Permits a school district or county office of education to provide epinephrine auto-injectors to trained personnel, and permits trained personnel to utilize these epinephrine auto-injectors to provide emergency medical aid to persons suffering from an anaphylactic reaction.
- Establishes EMSA within the California Health and Human Services Agency, and requires EMSA, among other things, to develop planning and implementation guidelines for emergency medical services systems which address specified components, including manpower and training, communications, transportation, system organization and management, data collection and evaluation, and disaster response.
This bill:
- Permits a health care provider to issue a prescription for an epinephrine auto-injector to an authorized entity, as defined by this bill, if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, who is trained and has a current epinephrine auto-injector certification card issued by EMSA.
- Defines an “authorized entity,” for purposes of this bill, as any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course approved by EMSA for the emergency use of epinephrine auto-injectors, as specified in existing law.
- Requires an authorized entity that possesses and makes available epinephrine auto-injectors to create and maintain on its premises an operations plan that includes all of the following:
- The name and contact number for the health care provider who prescribed the epinephrine auto-injector;
- Where and how the epinephrine auto-injector will be stored;
- The names of the designated employees or agents who have completed the required training program and who are authorized to administer the epinephrine auto-injector;
- How and when the epinephrine auto-injector will be inspected for an expiration date; and,
- The process to replace the expired epinephrine auto-injector, including the proper disposal of the expired or used epinephrine auto-injector in a sharps container.
- Requires an authorized entity that possesses and makes available epinephrine auto-injectors to submit to EMSA a report of each incident involving the use of an epinephrine auto-injector, within 30 days after each use. Requires EMSA to annually publish a report that summarizes all reports submitted to it under this bill.
- Permits a pharmacy to furnish epinephrine auto-injectors to an authorized entity, as defined by this bill, if both of the following requirements are met:
- The epinephrine auto-injectors are furnished exclusively for use by, or in connection with, an authorized entity; and,
- An authorized health care provider provides a prescription that specifies the quantity of epinephrine auto-injectors to be furnished.
- Requires the pharmacy to label each epinephrine auto-injector dispensed pursuant to the provisions of this bill with all of the following; the name of the person or entity to whom the prescription was issued; the designations “Section 1797.197a Responder” and “First Aid Purposes Only;” and the dosage, use, and expiration date.
- Requires each epinephrine auto-injector prescription dispensed pursuant to the provisions of this bill to include the manufacturer’s product information sheet for the epinephrine auto-injector.
- Requires records regarding the acquisition and disposition of epinephrine auto-injectors to be maintained by the authorized entity for a period of three years from the date the records were created, and requires the authorized entity to be responsible for monitoring the supply of epinephrine auto-injectors and ensuring the destruction of expired epinephrine auto-injectors.
- Permits an epinephrine auto-injector dispensed pursuant to the provisions of this bill to be used only for the purpose, and under the circumstances, specified under existing law for emergency use of epinephrine auto-injectors.
- Provides authorized entities, as defined by this bill, with immunity from civil liability for damages resulting from any act or omission, other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an epinephrine auto-injector by any one of its employees, volunteers, or agents who is a lay rescuer, as defined. Prohibits the failure of an authorized entity to possess or administer an epinephrine auto-injector from resulting in civil liability.
FISCAL EFFECT:
According to the Assembly Appropriations Committee, minor one-time GF costs to CDPH to develop a form, and ongoing GF costs not likely to exceed $50,000 annually to compile reports and publish a summary.
PRIOR VOTES:
Assembly Floor: | 78 - 0 |
Assembly Appropriations Committee: | 17 - 0 |
Assembly Judiciary Committee: Assembly Business and Professions Committee: | 9 - 0 14 - 0 |
Assembly Rules Committee: | 10 - 0 |
COMMENTS:
- Author’s statement. According to the author, food allergies, which can sometimes lead to a life-threatening allergic reaction, or anaphylaxis, are a large and growing public health problem. Today, an estimated one out of 13 children and one out of 20 adults in the U.S. has a food allergy, a considerably higher number than estimates only a few years ago. Additional children and adults who are allergic to insect stings and other factors can result in anaphylaxis. Anaphylaxis to food allergies results in approximately 90,000 emergency department visits each year in the U.S. Anaphylaxis results in approximately 1,500 deaths annually. This issue is serious and 47 states, including California, now have laws to allow or mandate schools to stock epinephrine auto-injectors. Schools are not the only place where children can come into contact with allergens capable of causing anaphylaxis. Greater access is needed to allow businesses, organization and other entities to stock epinephrine auto-injectors and allow for trained employees, agents and others to use those auto-injectors in an emergency. This legislation would expand access and allow day care, colleges and universities, summer and day camps, restaurants, sports arenas, sports leagues, scout troops, before and after school programs, recreational parks and other places where children and adults could come into contact with potentially life-threatening allergens to stock epinephrine auto-injectors and be better prepared in the event of an emergency. It would not require any entity to stock epinephrine auto-injectors, but would simply allow it.
- What is anaphylaxis? According to the National Institutes of Health, anaphylaxis is a severe, whole-body allergic reaction to a chemical that has become an allergen. After being exposed to a substance such as bee sting venom, the person's immune system becomes sensitized to it. When the person is exposed to that allergen again, an allergic reaction may occur. Anaphylaxis happens quickly after the exposure, is severe, and involves the whole body. Tissues in different parts of the body release histamine and other substances. This causes the airways to tighten and leads to other symptoms. Some drugs (morphine, x-ray dye, aspirin, and others) may cause an anaphylactic-like reaction (anaphylactoid reaction) when people are first exposed to them. These reactions are not the same as the immune system response that occurs with "true" anaphylaxis. However, the symptoms, risk for complications, and treatment are the same for both types of reactions. Anaphylaxis can occur in response to any allergen. Anaphylaxis is life-threatening and can occur at any time. Risks include a history of any type of allergic reaction.
- What is an epinephrine auto-injector? An epinephrine auto-injector is a medical device used to deliver a measured dose of epinephrine (also known as adrenaline) using auto-injector technology, most frequently for the treatment of acute allergic reactions to avoid or treat the onset of anaphylaxis. The EpiPen (and the version for smaller children, the EpiPen Jr.) are commonly used epinephrine auto-injectors. According to Mylan, which makes the EpiPen and EpiPen Jr., the EpiPen contains 0.3mg of epinephrine and is intended for those who weigh 66 pounds or more, while the EpiPen Jr. contains 0.15mg, and is intended for patients weighing between 33 to 66 pounds. Mylan’s product information states that it is not known if EpiPen and EpiPen Jr. are safe and effective in children who weigh less than 33 pounds. The devices are intended to be injected into the middle of the outer thigh, and patients are directed not to inject the device into a vein, buttock, fingers, toes, hands or feet.
- Study on unintentional injections. An article published in the February 2010 issue of the Journal of Allergy and Clinical Immunology, Voluntarily reported unintentional injections from epinephrine auto-injectors, found that from 1994 to 2007, a total of 15,190 unintentional injections from epinephrine auto-injectors were reported to US Poison Control Centers, with 60% of those reported from 2003 to 2007. Those unintentionally injected had a median age of 14 years, and 85% were injected in a home or other residence. Management of the individual was documented in only 4101 of the cases. In these 4101 cases, 49% of the clinical effects were described as “minor,” 20% were described as “minimal clinical effects, not followed,” and 15% were described as “moderate.” Only 27 cases (0.2%) were reported as “major effect,” which was described as “significant signs or symptoms.” Most of the unintentional injections (76%) were in a finger or thumb.
- Double referral. This bill is double referred. Should it pass out of this committee, it will be referred to the Senate Judiciary Committee.
- Prior legislation. SB 738 (Huff, Chapter 132, Statutes of 2015), provided qualified immunity to a physician who issues a prescription for an epinephrine auto-injector to a school district, county office of education, or charter school.
SB 1266 (Huff, Chapter 321, Statutes of 2014), required school districts, county offices of education, and charter schools to provide emergency epinephrine auto-injectors to school nurses or trained personnel who have volunteered, as specified. Authorized school nurses or trained personnel to use the epinephrine auto-injectors to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
SB 669 (Huff, Chapter 725, Statutes of 2013), permitted a prehospital emergency medical care person, first responder, or a lay rescuer to use an epinephrine auto-injector to render emergency care to another person if certain requirements are met, including obtaining specified training and certification. Permitted a health care provider to issue a prescription, and permits a pharmacy to dispense, an epinephrine auto-injector to a person who presents current certification as meeting the requirements of this bill. Provided immunity from civil liability to persons who administer an epinephrine auto-injector in conformance with this bill.
AB 559 (Wiggins, Chapter 458, Statutes of 2001), established provisions of law that permit a school district or county office of education to provide emergency epinephrine auto-injectors to trained personnel, and permit trained personnel to utilize these epinephrine auto-injectors to provide emergency medical aid to persons suffering from an anaphylactic reaction at a school or during a school activity. - Support. This bill is co-sponsored by Mylan and the Allergy and Asthma Network. Mylan, which is a manufacturer of generic and specialty medications, including epinephrine auto-injectors, states in support that while California has made great strides to address anaphylaxis-related tragedies, more can be done to ensure the state is better prepared. Mylan states that this bill would build upon California’s current school access law and expand access to this critical medication. The Allergy and Asthma Network (Network) states in support that venues that wish to stock epinephrine will ensure staff is trained to identify and respond to life-threatening anaphylactic reactions. According to the Network, the data shows that death from anaphylaxis occurs more often when the individual is away from home and there is either a delay before epinephrine is administered or it is not given at all. The American Red Cross also support this bill, stating that this bill strives to protect the millions of Californians who are at risk for anaphylactic shock, and will also protect the businesses that obtain a prescription for epinephrine with liability protection. The California Retailers Association states in support that this bill sets sufficient training requirements for employees and volunteers and establishes a detailed tracking process for when epinephrine auto-injectors are used. The California Chapter of the American College of Emergency Physicians states that this bill will save lives by increasing the availability of epinephrine auto-injectors and the training for their use by lay persons. The American Latex Allergy Association states that one in 13 children and one in 20 adults has a food allergy, additionally, others have insect and other non-food allergies that trigger anaphylactic shock, and that epinephrine auto-injectors are crucial for treating anaphylaxis. The SF Bay Area Food Allergy Network states that while legislation providing epinephrine auto-injectors in schools was a great step forward, there is no such measure available to day care centers and preschools, and this bill will give them the ability to be better prepared to respond in an allergic emergency.
- Oppose unless amended. Food Allergy Research and Education (FARE), states that it is opposed to this bill unless amended to add back important indemnification language recently removed from the bill. FARE states that it strongly supports the intent of the bill as epinephrine is the only medication that can stop the symptoms of a severe, life-threatening allergic reaction. However, FARE states that the bill should be amended to include liability protection for physicians writing standing orders to public entities. Without explicit liability protection, FARE states that physicians are reluctant to write these standing orders, and public venues may not be able to acquire epinephrine. FARE points out that in 2014, the legislature passed SB 1266 (Huff ) to require schools to stock epinephrine. SB 1266 did not provide indemnification for health care providers, and FARE states as a result, it was difficult, if not impossible, for schools to obtain the epinephrine auto-injectors. FARE states that it wasn’t until the following year that SB 738 (Huff) passed, providing indemnification for physicians writing the standing orders. According to FARE, across the country language such as that from SB 738 has passed, allowing physicians to assist thousands of schools by writing standing orders that allow trained, authorized personnel to safely administer epinephrine in emergency situations. The Allergy and Asthma Network, a former co-sponsor of this bill, is now also opposed unless amended, for similar reasons to FARE. Finally, the California Society of Allergy, Asthma and Immunology (CSAAI) opposes this bill unless amended to include liability protection for physicians writing epinephrine prescriptions, and also to include “education and training standards.” In addition, CSAAI states that epinephrine devises do have a “use by date” and should be checked regularly for efficacy purposes.
SUPPORT AND OPPOSITION:
Support: Mylan (co-sponsor)
American Latex Allergy Association
American Red Cross
California Chapter of the American College of Emergency Physicians
California Retailers Association
SF Bay Area Food Allergy Network
Two individuals
Oppose: Food Allergy Research and Education (unless amended)
Allergy and Asthma Network (unless amended)
California Society of Allergy, Asthma and Immunology (unless amended)
-- END --
Date of Hearing: January 21, 2016
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Jimmy Gomez, Chair
ABPCA Bill Id:AB 1386
Author:(Low) – As Amended Ver:January 13, 2016
Policy Committee: | Judiciary | Vote: | 9 - 0 |
Business and Professions | 14 - 0 | ||
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: No
SUMMARY:
This bill allows authorized entities, as defined, to procure and store epinephrine auto-injectors ("epi-pens") to treat anaphylaxis, a potentially life-threatening reaction. It also:
- Authorizes a pharmacy to furnish epinephrine auto-injectors to an authorized entity.
- Provides civil immunity to authorized entities for specified acts or omissions.
- Defines “authorized entity” as any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a specified training course.
- Allows a health care provider to issue a prescription to a prehospital emergency medical care person, a lay rescuer or an authorized entity that meets specified criteria.
- Requires authorized entities to submit to the California Department of Public Health (CDPH), on a form developed by the department, a report of each incident on the authorized entity’s premises that involves the administration of an epinephrine auto-injector.
- Requires CDPH to annually publish a report that summarizes and analyzes all reports submitted to it.
FISCAL EFFECT:
Minor one-time GF costs to CDPH to develop a form, and ongoing GF costs not likely to exceed $50,000 annually to compile reports and publish a summary.
COMMENTS:
- Purpose. This bill builds on several years of legislation to make epi-pens more widely available in order to prevent life-threatening complications from anaphylaxis. The bill is sponsored by Mylan, a company that manufactures epi-pens.
- Background. Common foods, products, and even medications may cause severe and life-threating allergic reactions, or anaphylaxis. Although anaphylaxis can be fatal if untreated, a person who experiences anaphylaxis can be kept alive by the prompt administration of epinephrine until transported to an emergency room. An epi-pen is a relatively simple and easy-to-use prescription product that provides an appropriate dose of epinephrine. It can be self-administered by the victim or by someone else. This bill will allow authorized entities, such as businesses, to stock epi-pens for use in an emergency situation.
- Prior Legislation.
- SB 738 (Huff), Chapter 132, Statutes of 2015, limits physician liability for issuance of a prescription or order for an epi-pen.
- SB 1266 (Huff), Chapter 321, Statutes of 2014, requires schools to provide emergency epi-pens to school nurses or trained personnel who have volunteered, and permits their use.
- SB 669 (Huff), Chapter 725, Statutes of 2013, permits a prehospital emergency medical care person, first responder, or lay rescuer to obtain and use an epi-pen in emergency situations.
- AB 559 (Wiggins), Chapter 458, Statutes of 2001, allowed school districts to provide emergency epi-pens to trained personnel, and permits their use.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
Date of Hearing: January 15, 2016
ASSEMBLY COMMITTEE ON JUDICIARY
Mark Stone, Chair
ABPCA Bill Id:AB 1386
Author:(Low) – As Amended Ver:January 13, 2016
SUBJECT: Emergency medical care: epinephrine auto-injectors
KEY ISSUES:
- Should doctors be permitted to prescribe epinephrine auto-injectors (AUTo-INJECTOR) to an entity, so long as the entity employs at least one person trained to administer the auto-injector to a person displaying symptons of anaphylaxis?
- Should an entity that obtains an auto-injector pursuant to a prescription be immune from liability for harm caused by the good faith use of the auto-injector by one of its trained employees, volunteers, or agents?
SYNOPSIS
This bill seeks to expand the use of epinephrine auto-injectors (sometimes known as "epi-pens"). These relatively easy-to-use devices are used to treat anaphylaxis, a life-threatening condition that may result from an allergic reaction or hypersensitivity to a particular substance. The bill is sponsored by Mylan, a company that manufactures epi-pens. Prescriptions for epi-pens are typically written to persons who suffer from an allergy or related condition that could cause an anaphylactic reaction. Most often these persons self-administer by pressing the device into the thigh. However, recent legislation authorized doctors to write prescriptions for epi-pens to prehospital emergency medical personnel and "lay rescuers," that is, non-professionals who have undergone prescribed training to recognize anaphylaxis and to properly administer the device if needed. Existing law also permits an authorized physician to prescribe epi-pens to school districts for use by school nurses or other school staff who have voluntarily undergone required training. Off-duty emergency medical personnel, lay rescuers, and school personnel are afforded qualified immunity from liability if they administer the device "in good faith and not for compensation." This bill would expand existing law in two ways: first, it would allow a health care provider to prescribe, and a pharmacist to dispense, epi-pens to an "authorized entity," which in turn is defined as any entity that employs, or uses as a volunteer, at least one person trained to use the epi-pen. In other words, the employee or volunteer would need to qualify as a "lay rescuer" under existing law. The bill would also grant the authorized entity qualified immunity from liability for civil damages resulting from the good faith efforts of its trained employees, volunteers, or agents. The author and sponsor contend that such immunities are required in order to assuage the concerns of businesses and other entities that might otherwise stock epi-pens, but are reluctant to do so because they fear potential liability. The bill passed out of the Assembly Business and Professions Committee earlier this week.
SUMMARY: Permits a medical provider to prescribe epinephrine auto-injectors to an "authorized entity," as defined, and grants immunity from liability to the authorized entity for any harm caused by authorized use of the device. Specifically, this bill:
- Authorizes a pharmacy to furnish an epinephrine auto-injector (auto-injector) to an authorized entity, as specified. Defines "authorized entity" to mean an entity that employs at least one person, or utilizes at least one volunteer or agent, that has voluntarily completed a prescribed training course.
- Provides that an authorized entity shall not be liable for any civil damages resulting from an act or omission, other than an act or omission constituting gross negligence or willful or wanton misconduct, related to the administration of the auto-injector by one of its trained employees, volunteers, or agents. Specifies that the failure of an authorized entity to possess or administer an auto-injector shall not result in civil liability. Specifies further that the immunity provided by this provision does not affect any other immunity or defense that is available under any other state law.
- Permits an authorized health care provider to issue a prescription for an auto-injector to an authorized entity, as defined, if the authorized entity submits evidence that it employs at least one person, or utilizes at least one volunteer or agent, who is trained to administer an auto-injector, as required under existing law.
- Requires an authorized entity that possesses and makes available auto-injectors to develop an operations plan that, among other things, provides for the proper storage, regular inspection, and replacement of auto-injectors, and requires the authorized entity to submit to the State Department of Public Health a report relating to the use of auto-injectors on its premises.
EXISTING LAW:
- Provides that no person who in good faith, and not for compensation, renders medical or nonmedical care at the scene of an emergency shall be liable for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct. (Health and Safety Code Section 1799.102.)
- Permits a "prehospital emergency medical care person" or a "lay rescuer," as defined, to use an epinephrine auto-injector in order to render emergency care to another person who appears to be experiencing anaphylaxis so long as certain requirements are met, including, among other things, that the person using the epinephrine auto-injector has completed a prescribed course of training and that the epinephrine auto-injector has been obtained by prescription from an authorized health care provider. (Health and Safety Code Section 1797.197a.)
- Provides that a prehospital emergency medical care person or lay rescuer who administers an epinephrine auto-injector, in good faith and not for compensation, to another person who appears to be experiencing anaphylaxis at the scene of an emergency is not liable for any civil damages resulting from his or her acts or omissions in administering the epinephrine auto-injector, if he or she complies with specified statutory requirements, and so long as his or her conduct does not constitute gross negligence or willful or wanton misconduct. (Civil Code Section 1714.23.)
- Requires a school district or county office of education to provide emergency epinephrine auto-injectors to school nurses or trained volunteers, as specified, and allows those individuals to utilize epinephrine auto-injectors to provide emergency medical aid to persons suffering from anaphylaxis. Requires a school nurse or a school administrator to obtain a prescription for the epinephrine auto-injectors from an authorized physician, and provides that the prescribing physician shall not be subject to professional review, civil liability, or criminal prosecution for prescribing the epinephrine auto-injectors, unless the physician's issuance of the prescription constitutes gross negligence or willful and malicious conduct. (Education Code Section 49414(a)-(g).)
FISCAL EFFECT: As currently in print this bill is keyed fiscal.
COMMENTS: As is well-documented in a number of medical studies, certain common foods, products, and even medications may cause severe and life-threating allergic reactions, or anaphylaxis. Although anaphylaxis can be fatal if untreated, a person who experiences anaphylaxis can be kept alive by the prompt administration of epinephrine until transported to an emergency room. An epinephrine auto-injector is a relatively simple and easy-to-use prescription product that provides an appropriate dose of epinephrine, whether the auto-injector is self-administered by the victim, or by someone else.
While all agree that epinephrine auto-injectors are relatively simple and easy-to-use, the devices may only be obtained by prescription under federal law. Most commonly, they are prescribed to a person with an allergy that is known to cause anaphylaxis. However, a person – especially a child – may not always know that he or she has such an allergy prior to suffering the first anaphylactic episode. To address this dilemma, existing law in California allows doctors, in limited contexts, to prescribe auto-injectors to persons trained to recognize the symptoms of anaphylaxis and safely administer the devices. For example, under the California Education Code, doctors may prescribe auto-injectors to school districts for use by school nurses or other school employees who have undergone prescribed training on how to recognize the symptoms of anaphylaxis and administer the auto-injector. In addition, a provision in the Health & Safety Code permits doctors to prescribe auto-injectors to prehospital emergency care persons and "lay rescuers" who have undergone statutorily prescribed training and hold a current certification. Consistent with California's general Good Samaritan statute (Health and Safety Code Section 1799.102), existing law also affords qualified immunity to off-duty prehospital emergency care persons and trained lay rescuers for injuries caused by their use of the auto-injector, so long as they act in "good faith and not for compensation." Also consistent with other statutory immunities, the person administering the auto-injector is only afforded a qualified immunity from liability, meaning that immunity does not extend to conduct that constitutes gross negligence or willful or wanton misconduct.
This bill would expand existing law in two ways. First, it would allow a physician to prescribe, and a pharmacist to dispense, the auto-injectors to an "authorized entity." The bill defines an "authorized entity" to mean any entity (whether a private business or government agency, other than a school district) that has at least one employee, volunteer, or agent that has undergone prescribed training to become a lay rescuer. Because existing law requires training before one can be authorized to administer the device to another person, an entity that did not have a trained employee or volunteer, therefore, could not obtain a prescription to stock the auto-injectors. Second, this bill would give an authorized entity qualified immunity from liability for an injury caused by an employee or volunteer acting in good faith and not for compensation. Arguably, such immunity is not necessary, as the authorized entity could only be vicariously liable for the acts of an employee or volunteer if the employee or volunteer would have been liable. As required by law, however, the employee or volunteer will necessarily be a "lay rescuer," and a lay rescuer is already protected from liability when acting in good faith and not for compensation – unless, of course, the conduct rises to gross negligence or willful or wanton misconduct, in which case the lay rescuer is appropriately subject to civil liability for that conduct. Nonetheless, the author and sponsor contend that entities that might otherwise keep auto-injectors stocked for use by trained employees are reluctant to do so because of fears of liability. The express liability afforded by this bill is intended by the author to assuage those fears.
The "Good Samaritan" Law and the Unintended Consequences of Express Immunities. In recent years this Committee has heard, and the Legislature has enacted, bills seeking an express immunity from liability for lay people (or off-duty professionals) who voluntarily render medical aid in a specific emergency situation, such as administering cardiopulmonary resuscitation (CPR) or applying an automated external defibrillator (AED), among other voluntary actions. Under existing common law tort rules, however, a person who voluntarily comes to the aid of another person suffering a medical emergency would be immune from liability so long as that person acted in a reasonably prudent manner under the circumstances. In addition, in 2009, California adopted a so-called "Good Samaritan" statute. (The term refers to the parable in the Gospel of Luke about the "lowly" Samaritan who came to the aid of a stranger left for dead while supposedly more upstanding citizens ignored the cries of the dying man.) California's Good Samaritan statute (Heath & Safety Code Section 1799.102) grants qualified immunity to any person who renders medical or non-medical aid in an emergency, so long as that person acts in good faith and not for compensation, and so long as that person's conduct is not grossly negligent or willful or wanton. Accordingly, provisions in existing law that have granted immunity to persons performing CPR or administering AED devices or epinephrine auto-injectors may be unnecessary, since any of these acts would most certainly qualify as rendering medical aid in an emergency. For example, it is difficult to imagine a situation in which a person who had complied with the requirements of this bill (or even an untrained lay person who voluntarily renders aid to a victim of anaphylaxis by providing or assisting the victim with an auto-injector, which is not specifically authorized by this bill) would not already be protected from liability under the Good Samaritan statute. While providing express immunity for specific medical emergencies may be unnecessary in light of the Good Samaritan statute, one could argue that this bill – and prior bills like it – is a harmless and potentially useful clarification of existing law.
ARGUMENTS IN SUPPORT: Mylan, a company that manufactures medical products, including epinephrine auto-injectors, sponsored this bill because it will "expand access to epinephrine auto-injectors used to treat severe allergic reactions or anaphylaxis." Mylan cites statistics on the number of anaphylaxis deaths, suggesting that such tragedies might have been avoided had the victim had timely access to an epinephrine auto-injector. This is especially true in instances where the victim had never experienced anaphylaxis, was not aware of his or her allergy, and therefore would not have possessed an auto-injector.
Mylan acknowledges that California has "made great strides to address this issue," especially in legislation targeting schools and the training of lay rescuers, but the company believes that "more can be done to ensure the state is better prepared in the event that children or adults experience an anaphylactic reaction for the first time or in a public location." While Mylan believes that providing auto-injectors to schools was an important "first step," it notes that there are many other public places – including preschools, colleges, workplaces, and restaurants – where someone could experience an anaphylactic reaction without having an auto-injector on hand. Finally, Mylan notes that nineteen other states "have already passed legislation that allows entities to stock epinephrine auto-injectors and trained individuals to administer them." Mylan argues that California should do the same.
REGISTERED SUPPORT / OPPOSITION:
Support
Mylan, Inc. (sponsor)
Allergy & Asthma Network
Allergy Station
American Latex Allergy Association
American Red Cross
California ACEP
San Francisco Bay Area Food Allergy Network
Two individuals
Opposition
None on file
Analysis Prepared by: Thomas Clark / JUD. / (916) 319-2334
Date of Hearing: January 12, 2016
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Susan Bonilla, Chair
ABPCA Bill Id:AB 1386
Author:Low – As Amended Ver:January 5, 2016
NOTE: This bill is double referred, and if passed by this Committee, it will be referred to the Assembly Committee on Judiciary.
SUBJECT: Emergency medical care: epinephrine auto-injectors.
SUMMARY: Permits a pharmacy to furnish epinephrine auto-injectors (EAIs) to an authorized entity, as specified, if the EAIs are furnished exclusively for use at or in connection with an authorized entity, as specified; an authorized health care provider provides a prescription; and, the records are maintained by the authorized entity for three years. Requires the authorized entity to create and maintain an operations plan related to its use of EAIs; makes other technical and clarifying amendments; and, contains specified immunity provisions.
EXISTING LAW:
- Authorizes a pharmacy to furnish an EAI to a school district, county office of education, or charter school, as specified, if the EAIs are furnished for use at a school site and a physician and surgeon provide a written order that specifies the quantity of EAIs to be furnished. Business and Professions Code (BPC) Section 4119.2(a)
- Requires the records regarding acquisition and disposition of EAIs be maintained by the school district, county office of education, or charter school for a period of three years, and requires those entities to be responsible for monitoring the supply of EAIs and ensuring the destruction of expired EAIs. (BPC 4119.2(b))
- Authorizes a pharmacy to dispense EAIs to a prehospital emergency medical care person or lay rescuer for the purpose of rendering emergency medical care, as specified, if conditions are met, including that a physician or surgeon provides a written order that specifies the number of EAIs to be dispensed; the individual receiving the prescription has obtained the certificate of training, as specified; the prescription label specifies that the prescription is for "First Aid Purposes Only;" and a new prescription is required for any additional EAIs. (BPC Section 4119.3)
- Requires a pharmacy to label each EAI with the name of the person to whom the prescription was issued, the designations, "Section 1797.197a Responder" and "First Aid Purposes Only," the dosage use and expiration date, and requires dispensed prescriptions to include the manufacturer's product information sheet. (BPC Section 4119.3)
- Requires school districts, county offices of education, and charter schools to provide emergency EAIs to school nurses or trained personnel who have volunteered, as specified, and authorizes school nurses or trained personnel to use EAIs to provide emergency medical aid to persons suffering, or reasonably believed to be suffering from an anaphylactic reaction. Education Code (EDC) Section 49414(a))
- Permits each private elementary and secondary school in the state to voluntarily determine whether or not to make EAIs and trained personnel available at its school, as specified. (EDC Section 49414(c))
- Authorizes a prehospital emergency medical care person or lay rescuer to use an EAI to render emergency care to another person if all of the following requirements are met:
- The EAI is legally obtained by prescription from an authorized health care provider. An authorized health care provider may issue a prescription for an EAI to a person, as specified, for the purpose of rendering emergency care to another person, upon presentation of current certification demonstrating that person is trained and qualified to administer an EAI as a prehospital emergency medical care person or lay rescuer;
- The EAI is used on another, with the expressed or implied consent of that person, to treat anaphylaxis;
- The EAI is stored and maintained as directed by the manufacturer’s instructions for that product;
- The person using the EAI has successfully completed a course of training with an authorized training provider, and has current certification of training issued by the provider;
- The EAI obtained by prehospital emergency medical care personnel, as specified, shall be used only when functioning outside the course of the person’s occupational duties, or as a volunteer, pursuant to this section; and,
- The emergency medical services system is activated as soon as practicable when an EAI is used. (Health and Safety Code (HSC) Section 1797.197a)
THIS BILL:
- Permits a pharmacy to furnish EAIs to an authorized entity, as specified, if both the following conditions are met:
- The EAIs are furnished exclusively for use at or in connection with an authorized entity; and for use by its employees, volunteers, and agents, first responder, or by a family member or caregiver of the person who appears to be experiencing anaphylaxis, as specified, or by the person who appears to be experiencing anaphylaxis, and,
- An authorized health care provider provides a prescription that specifies the quantity of EAIs to be furnished.
- The EAIs are furnished exclusively for use at or in connection with an authorized entity; and for use by its employees, volunteers, and agents, first responder, or by a family member or caregiver of the person who appears to be experiencing anaphylaxis, as specified, or by the person who appears to be experiencing anaphylaxis, and,
- Requires a pharmacy to label each EAI dispensed with all of the following information:
- The name of the person or entity to whom the prescription was issued;
- The designations "Section 1797.197a Responder" and "First Aid Purposes Only"; and,
- The dosage, use, and expiration date.
- The name of the person or entity to whom the prescription was issued;
- Requires each dispensed prescription to include the manufacturer's product information sheet for the EAI.
- States that an EAI dispensed, as specified, may be used only for the purpose and under the circumstances described in Section 1797.197a of the HSC.
- Requires records regarding the acquisition and disposition of EAIs to be maintained by the authorized entity for a period of three years from the date the records were created and requires the authorized entity to be responsible for monitoring the supply of EAIs and ensuring the destruction of expired EAIs.
- States that an authorized health care provider that prescribes or dispenses an EAI to a person authorized to use an EAI to render emergency care, as specified, or to an authorized entity is not liable for any civil damages resulting from any act or omission related to the provision of an EAI.
- Relieves a person who conducts the training as specified in HSC Section 1797.197a, from liability for any civil damages resulting from any act or omission of the lay rescuer, as specified, who renders emergency care by administering the EAI.
- Relieves any authorized entity from liability for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct connected to the administration of an EAI by any one of its employees, volunteers, or agents who is a lay rescuer, as specified, or who in good faith, and not for compensation, renders emergency medical or nonmedical care at the scene of an emergency.
- States that the failure of an authorized entity to possess or administer an EAI cannot result in civil liability.
- Specifies that above the provisions does not affect any other immunity or defense that is available under law, including, but not limited to, the immunity from liability for any civil damages resulting from any act or omission other than an act or omission constituting gross negligence or willful or wanton misconduct of a person who in good faith, and not for compensation, renders emergency medical or nonmedical care at the scene of an emergency as provided by HSC Section 1799.102.
- Defines an “authorized entity” as any for-profit, nonprofit, or government entity or organization that employs at least one person or utilizes at least one volunteer or agent that has voluntarily completed a training course as specified.
- Permits an authorized health care provider to prescribe EAIs to an authorized entity.
- Requires that an EAI, which is acquired by an authorized entity, be stored in a location readily accessible in an emergency and in accordance with the EAI instructions for use and any additional requirements that may be established by the Authority.
- Requires an authorized entity that possesses and makes available EAIs to do both of the following:
- Create and maintain on its premises an operation plan that includes all of the following:
- The name and contact number for the authorized health care provider who prescribed the EAI;
- Where and how the EAI will be stored;
- The names of the of the designated employees or agents who have completed the training program as required and who are authorized to administer the EAI;
- How and when the EAI will be inspected for an expiration date; and,
- The process to replace the expired EAI, including the proper disposal of an expired EAI.
- The name and contact number for the authorized health care provider who prescribed the EAI;
- Submit to the Department of Public Health (DPH) on a form developed by the DPH, a report of each incident on the authorized entity's premises that involves the administration of an EAI, and requires the DPH to annually publish a report that summarizes and analyzes all reports submitted to it.
- Create and maintain on its premises an operation plan that includes all of the following:
- Provides that no reimbursement is required by this bill pursuant to Section 6 of Article XIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction.
FISCAL EFFECT: Unknown. This bill is keyed fiscal by the Legislative Counsel.
COMMENTS:
Purpose. This bill is sponsored by Mylan. According to the author, "Food allergies, which can sometimes lead to a life-threatening allergic reaction or anaphylaxis, are a large and growing public health problem. Today, an estimated one out of 13 children and [one] out of 20 adults in the U.S. has a food allergy, a considerably higher number than estimated only a few [years] ago. [Additionally] children and adults are allergic to insect stings and other factors that can result in anaphylaxis. Unfortunately, over the past several years, there have been several high profile anaphylaxis-related tragedies around the country in schools and outside of schools. Deaths in Illinois in 2011, Georgia and Virginia in 2012, California, Texas and New York (in 2013) resulted in significant attention to the issue and much discussion on how to best address it…
This issue is serious and 47 states, including California, now have laws to allow or mandate schools to stock [EAIs]. At least 54,000 schools across the U.S. are stocking [EAIs]. But schools are not the only place where children can come into contact with allergens capable of causing anaphylaxis. Greater access is needed to allow businesses, organization[s] and other entities to stock [EAIs] and allow for trained employees, agents and others to use those [EAIs] in an emergency.
This legislation would expand access and allow day care [facilities], colleges and universities, summer and day camps, restaurants, sports arenas, sports leagues, scout troops, before and after school programs, recreational parks and other places where children and adults could come into contact with potentially life-threatening allergens to stock [EAIs] and be better prepared in the event of an emergency. It would not require any entity to stock [EAIs], but would simply allow it."
Background. An EAI is used for the emergency treatment of severe allergic reactions (including anaphylaxis) to insect bites or stings, medicines, foods, or other substances. It is also used to treat anaphylaxis caused by unknown substances or triggered by exercise. To help increase access to EAIs in the event of an anaphylactic emergency, this bill will allow a pharmacy to furnish EAIs to authorized entities such as recreation camps, colleges and universities, day care facilities, youth sports leagues and other businesses to be used by trained persons in the event of a potential anaphylactic emergency. In order for the entity to acquire the EAIs, they would need to obtain a prescription from an authorized health care provider who would be responsible for determining the appropriate number of EAIs to be dispensed. The representative of the authorized entity would need to meet the appropriate training requirements as approved by the Emergency Medical Services Authority (EMS).
The author notes, that while existing law allows individuals who have been trained in recognition of symptoms of allergic reactions and anaphylaxis to administer EAIs to others in an emergency situation, and provides liability protection for these individuals, current law does not allow a business, group, or other entity that the individual is employed by or associated with to obtain a prescription for an EAI or to have liability protection if the EAI is used on the entity's premises.
This bill would allow businesses, organizations, and other entities to obtain a prescription and to stock EAIs for use in an emergency if the business, organization or entity has employees, agents or others who are trained in recognition of anaphylaxis and the administration of EAIs. It would also provide liability protection to the business, organization, or entity that obtained the EAI and allow it to be used by a trained employee, agent, or other individual under certain circumstances. This bill does not mandate that an "authorized entity" participate in this voluntary program.
This bill seeks to create greater access to EAIs at locations where individuals could come into contact with allergens known to cause anaphylaxis in those persons with allergies.
Current Use of EAIs in California. SB 669 (Huff) Chapter 725, Statutes of 2013, authorized an off duty prehospital emergency medical care person or lay rescuer to use an EAI to render emergency care to another person. That bill required the EMS to establish and approve minimum standards for training in the use and administration of EAIs. In addition, EMS was required to approve the authorized training providers and determine the components to be included in the minimum training and requirements. In order to implement the training program required by SB 669, the EMS convened a work group of EMS stakeholders and subject matter experts to assist the EMS in the development of the training standards and the initial drafting of regulations to outline the training and certification process and requirements for a lay rescuer or off duty EMS personnel to obtain an EAI. The EMS concluded the regulatory process in October of 2015. Beginning January 1, 2016, the EMS can begin the process of reviewing and approving the required training programs to obtain the appropriate lay rescuer certification.
Other States. According to the author, in 2013 and 2014, Oregon, Florida, and Rhode Island passed legislation similar to what is included in this bill; in total there are 17 states that offer similar provisions for stockpiling EAIs outside of a school setting.
In 2013, President Obama signed into law the School Access to Emergency Epinephrine Act. The Act amends the Public Health Service Act, with respect to asthma-related grants for child health services, to give an additional preference to a state that allows self-administration of asthma and anaphylaxis medication (https://www.congress.gov/bill/113th-congress/senate-bill/1503/all-info). The Act requires elementary and secondary schools in such a state to: 1) permit trained personnel to administer epinephrine to a student reasonably believed to be having a reaction; 2) maintain a supply of epinephrine in a secure location that is easily accessible to trained personnel for such treatment; and, 3) have in place a plan for having on the school premises during operating hours one or more designated personnel trained in administration of epinephrine.
EAIs. According to one of the EAI's manufacturers' websites, there are two different doses of epinephrine available based on the weight of the individual. According to information provided by the American College of Allergy, Asthma and Immunology, common side effects of epinephrine may include anxiety, restlessness, dizziness, and shakiness. In addition, it was noted that after use of an EAI, it is recommended that an individual immediately visit a physician or an emergency room for medical treatment.
While EAIs appear to be commonly recommended as a method to treat specified anaphylactic conditions, EAIs are only available via a prescription from a licensed health care provider in the United States and cannot be purchased over-the-counter.
Previous Related Legislation. SB 738 (Huff), Chapter 132, Statutes of 2015, provides that an authorizing physician and surgeon will not be subject to professional review, liable in a civil action or be the subject of criminal prosecution for issuing a prescription or order, as specified, for an EAI, unless the physician or surgeon's issuance constitutes gross negligence or willful or malicious conduct.
SB 1266 (Huff), Chapter 321, Statutes of 2014, requires school districts, county offices of education (COE), and charter schools to provide emergency EAIs to school nurses or trained personnel who have volunteered, and authorizes school nurses or trained personnel to use EAIs to provide emergency medical aid to persons suffering, or reasonably believed to be suffering, from an anaphylactic reaction.
SB 669 (Huff), Chapter 725, Statutes of 2013, permits a prehospital emergency medical care person, first responder, or lay rescuer to obtain and use an EAI in emergency situations with certification of training, as specified.
AB 559 (Wiggins), Chapter 458, Statutes of 2001, allowed school districts or COEs to provide emergency EAIs to trained personnel, and permits trained personnel to utilize EAIs to provide emergency medical aid to persons suffering from an anaphylactic reaction.
ARGUMENTS IN SUPPORT: Mylan writes in support, "[This bill] would expand access and allow day care [facilities], colleges and universities, summer and day camps, sports arenas, sports leagues, scout troops, before and after school programs, recreational parks, and other places where children and adults could come into contact with potentially life-threatening allergens to obtain a prescription for and stock [EAIs], and allow trained personnel to administer them in emergencies. Oregon, Florida and Rhode Island passed legislation similar to [this bill] in 2013 and 2014. Eight states (Arkansas, Georgia, Kentucky, Indiana, Iowa, Oklahoma, West Virginia and Utah) have passed legislation this year and at least 27 states are considering similar legislation."
ARGUMENTS IN OPPOSITION:
None on file.
POLICY ISSUES FOR CONSIDERATION:
SB 669 established a voluntary procedure for a lay rescuer to meet training and certification requirements in order to obtain a prescription for an EAI. This bill would expand the current program by authorizing a business or other entity to stockpile EAIs if that business or entity has a trained person who holds the valid certification. In an effort to maintain the voluntary nature of the current program, the author may wish to specify that an authorized entity cannot require its employees or agents to obtain the voluntary training and certification as a condition of employment.
Additionally, this bill will authorize a pharmacy to furnish EAIs to authorized entities that have designated volunteers including employees, agents or other trained individuals who have met the appropriate training requirements to render emergency care to another person. Although this bill requires the authorized entity to allow only those individuals who hold the appropriate training to be able to use an EAI in the event of an anaphylactic emergency, it is unclear what the appropriate procedure would be when a person is experiencing an anaphylactic reaction at a business or other location and the trained volunteer is not available. The author may wish to consider clarifying the process or procedure for use and access to the EAIs when the trained lay rescuer, which holds the EMS certification, is not available.
AMENDMENTS:
The author has requested the following amendments to address technical issues raised by this committee, and other issues raised by the Assembly Committee on Judiciary.
On page, 3, in line 7, after "for" insert use at or in connection with an authorized entity. and strike lines 8-15.
On page 4, Strike lines 38-40.
On page 5, strike lines 1-12.
On page 5, in line 24, after "code" strike "or who, in good faith, and not for" and strike lines 25-26.
On page 5, in line 37, after "under" insert state and after "law" strike "including but not limited to, the immunity" and strike lines 38-40.
On page 6, strike lines 1-3.
On page 7, in line 12 after "(e)" strike "An authorized health care provider" and strike lines 13-19.
On page 9, in line 31 after "(c)." insert (e)(1) An authorized health care provider may issue a prescription for an epinephrine auto-injector to a prehospital emergency medical person or a lay rescuer for the purpose of rendering emergency care to another person upon presentation of a current certification demonstrating that the person is trained and qualified to administer an epinephrine author-injector, pursuant to this section or any other statute or regulation.
(2) An authorized health care provider may issue a prescription for an epinephrine auto-injector to an authorized entity, as defined in paragraph (2) of subdivision (a), if the authorized entity submits evidence it employs at least one person, or utilizes at least one volunteer or agent, that is trained and qualified to administer an epinephrine author-injector, pursuant to this section.
On page 9, strike lines 32-40.
On page 10, in line 15, after "auto-injector" insert or used epinephrine auto-injector in a sharps container.
REGISTERED SUPPORT:
Mylan (sponsor)
American Latex Allergy Association
American Red Cross
Sanofi
SF Bay Area Food Allergy Network
REGISTERED OPPOSITION:
None on file.
Analysis Prepared by: Elissa Silva / B. & P. / (916) 319-3301
Discussed in Hearing
Assembly Floor
Senate Floor
Senate Standing Committee on Judiciary
Senate Standing Committee on Health
Assembly Standing Committee on Judiciary
Assembly Standing Committee on Business and Professions
Bill Author
Bill Co-Author(s):